Amino Acid Index	Amino Acid	Population Mutation	Population Mutation (details)	Pathogenic Mutation	Pathogenic Mutation (details)	Bond Detail	Accessible Surface Area	Relative Accessible Surface Area	8-class DSSP Secondary Structure Properties	3-class DSSP Secondary Structure Properties	Exposure	Physiochemical Property	Acetylation Detail	Methylation Detail	O.GalNAc Detail	O.GclNAc Detail	Phosphorylation Detail	Sumoylation Detail	Ubiquitination Detail	Active Site	Metal Binding Site	binding Site	Site	Zinc Finger	Dna Binding	Nucleotide Phosphate Binding	Calcium Binding	Region	Repeat	Coiled Coil	Topological Domain	Peptide	Modified Residue	Motif	Domain	Intramembrane	Propetide	Lipidation	Glycosylation	Cross Links	Disulfide Bond	Transit Peptide	Transmembrane	Signal Peptide	Functional Site	Functional Binding Region	Sequence Motif Region	Modular Domain	Molecular Processing	Modified Residues
1	M	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
2	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
3	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
4	W	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
5	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
6	G	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
7	A	A>T; A>D	A>T (exome, AC = 2, AN = 251426, AF = 7.95463e-06); A>D (exome, AC = 1, AN = 251334, AF = 3.97877e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
8	P	P>A	P>A (exome, AC = 1, AN = 251496, AF = 3.97621e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
9	V	V>A	V>A (exome, AC = 1, AN = 251496, AF = 3.97621e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
10	P	P>S	P>S (exome, AC = 1, AN = 251496, AF = 3.97621e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
11	D	none	none	none	none	-	-1	-1	-	-	-	Negatively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
12	I	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
13	P	P>S	P>S (exome, AC = 11, AN = 251496, AF = 4.37383e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
14	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
15	D	none	none	none	none	-	-1	-1	-	-	-	Negatively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
16	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
17	A	A>S; A>V; R>Q	A>S (exome, AC = 1, AN = 250364, AF = 3.99418e-06); A>V (exome, AC = 1, AN = 250348, AF = 3.99444e-06); R>Q (exome, AC = 1, AN = 250388, AF = 3.9938e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
18	V	V>M; V>E	V>M (exome, AC = 1, AN = 250372, AF = 3.99406e-06); V>E (exome, AC = 2, AN = 250410, AF = 7.9869e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
19	E	E>Q; E>G; E>K	E>Q (exome, AC = 1, AN = 250480, AF = 3.99233e-06); E>G (exome, AC = 1, AN = 250460, AF = 3.99265e-06); E>K (genome, AC = 1, AN = 31398, AF = 3.18492e-05)	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
20	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
21	W	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
22	K	K>E	K>E (exome, AC = 3, AN = 250584, AF = 1.1972e-05); K>E (genome, AC = 2, AN = 31360, AF = 6.37755e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
23	P	P>T	P>T (exome, AC = 3, AN = 250586, AF = 1.19719e-05); P>T (genome, AC = 1, AN = 31384, AF = 3.18634e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
24	G	A>V	A>V (exome, AC = 5, AN = 250550, AF = 1.99561e-05); A>V (genome, AC = 1, AN = 31386, AF = 3.18613e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
25	A	A>T	A>T (exome, AC = 2, AN = 250474, AF = 7.98486e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
26	Q	Q>R	Q>R (exome, AC = 4, AN = 250604, AF = 1.59614e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
27	D	none	none	none	none	-	-1	-1	-	-	-	Negatively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
28	A	A>E	A>E (exome, AC = 1, AN = 250478, AF = 3.99237e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
29	S	S>N	S>N (exome, AC = 5, AN = 250436, AF = 1.99652e-05); S>N (genome, AC = 1, AN = 31406, AF = 3.1841e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
30	S	A>V	A>V (exome, AC = 1, AN = 250368, AF = 3.99412e-06); A>V (genome, AC = 1, AN = 31384, AF = 3.18634e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
31	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
32	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
33	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
34	G	G>E	G>E (exome, AC = 5, AN = 250288, AF = 1.9977e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
35	G	A>E	A>E (exome, AC = 1, AN = 250138, AF = 3.99779e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
36	S	A>V	A>V (exome, AC = 1, AN = 250068, AF = 3.99891e-06)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
37	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
38	C	A>V	A>V (exome, AC = 1, AN = 250024, AF = 3.99962e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
39	I	I>M	I>M (exome, AC = 3, AN = 249948, AF = 1.20025e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
40	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
41	R	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
42	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
43	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
44	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
45	R	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
46	M	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
47	P	P>L	P>L (exome, AC = 1, AN = 247700, AF = 4.03714e-06); P>L (genome, AC = 1, AN = 31358, AF = 3.18898e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
48	H	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
49	S	S>A; L>P	S>A (exome, AC = 1, AN = 247212, AF = 4.04511e-06); L>P (exome, AC = 3, AN = 246858, AF = 1.21527e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
50	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
51	G	G>E	G>E (exome, AC = 1, AN = 244508, AF = 4.08985e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
52	G	G>S; G>V	G>S (exome, AC = 1, AN = 244580, AF = 4.08864e-06); G>V (exome, AC = 424, AN = 244366, AF = 0.0017351); G>V (genome, AC = 207, AN = 31376, AF = 0.0065974)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
53	T	L>P	L>P (exome, AC = 4, AN = 243620, AF = 1.6419e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
54	A	A>S	A>S (exome, AC = 3, AN = 242842, AF = 1.23537e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
55	G	G>E; G>W	G>E (exome, AC = 1, AN = 240954, AF = 4.15017e-06); G>W (genome, AC = 1, AN = 31388, AF = 3.18593e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
56	V	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
57	G	G>R	G>R (exome, AC = 10, AN = 239540, AF = 4.17467e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
58	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
59	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
60	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
61	A	Q>R	Q>R (exome, AC = 2, AN = 230692, AF = 8.66957e-06); Q>R (genome, AC = 1, AN = 31384, AF = 3.18634e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
62	E	E>K	E>K (genome, AC = 1, AN = 31388, AF = 3.18593e-05)	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
63	P	P>L	P>L (genome, AC = 1, AN = 31384, AF = 3.18634e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
64	T	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
65	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
66	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
67	L	L>V	L>V (exome, AC = 2, AN = 204252, AF = 9.79183e-06); L>V (genome, AC = 2, AN = 31380, AF = 6.37349e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
68	T	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
69	R	R>G	R>G (exome, AC = 1, AN = 194166, AF = 5.15023e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
70	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
71	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
72	P	P>R	P>R (genome, AC = 1, AN = 31368, AF = 3.18796e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
73	P	P>L	P>L (exome, AC = 4, AN = 170228, AF = 2.34979e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
74	S	S>P	S>P (exome, AC = 1, AN = 170550, AF = 5.86338e-06)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
75	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
76	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
77	T	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
78	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
79	I	I>M	I>M (genome, AC = 1, AN = 31380, AF = 3.18674e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
80	R	R>C; R>H	R>C (exome, AC = 21, AN = 247792, AF = 8.47485e-05); R>H (exome, AC = 10, AN = 248466, AF = 4.0247e-05); R>C (genome, AC = 2, AN = 31400, AF = 6.36943e-05); R>H (genome, AC = 3, AN = 31398, AF = 9.55475e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
81	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
82	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
83	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
84	R	R>W; R>P	R>W (exome, AC = 1, AN = 249234, AF = 4.01229e-06); R>P (exome, AC = 1, AN = 249438, AF = 4.00901e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
85	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
86	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
87	G	G>D	G>D (exome, AC = 1, AN = 249994, AF = 4.0001e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
88	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
89	A	A>T; P>L	A>T (exome, AC = 1, AN = 250246, AF = 3.99607e-06); P>L (exome, AC = 1, AN = 250334, AF = 3.99466e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
90	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
91	K	K>R	K>R (exome, AC = 1, AN = 250606, AF = 3.99033e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
92	M	M>V; M>I	M>V (exome, AC = 7, AN = 250680, AF = 2.7924e-05); M>I (exome, AC = 1, AN = 250724, AF = 3.98845e-06); M>V (genome, AC = 2, AN = 31402, AF = 6.36902e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
93	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
94	G	G>A	G>A (exome, AC = 1, AN = 250844, AF = 3.98654e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
95	N	N>Y; T>M	N>Y (exome, AC = 1, AN = 250880, AF = 3.98597e-06); T>M (exome, AC = 85, AN = 250868, AF = 0.000338824)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	region	-	-	-
96	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	M1-E96: Transactivation AF-1 required for ligand-independent transactivation function	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	region	-	-	-
97	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
98	C	A>V	A>V (exome, AC = 1, AN = 251242, AF = 3.98023e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
99	S	A>V	A>V (exome, AC = 64415, AN = 251222, AF = 0.256407); A>V (genome, AC = 8331, AN = 31338, AF = 0.265843)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
100	V	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
101	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
102	G	G>R	G>R (exome, AC = 3, AN = 251388, AF = 1.19337e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
103	D	none	none	none	none	-	-1	-1	-	-	-	Negatively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
104	K	R>K	R>K (exome, AC = 1, AN = 251428, AF = 3.97728e-06); R>K (genome, AC = 2, AN = 31406, AF = 6.36821e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
105	A	P>L	P>L (exome, AC = 1, AN = 251424, AF = 3.97735e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
106	S	S>L; R>Q; S>W	S>L (exome, AC = 2, AN = 251408, AF = 7.9552e-06); R>Q (exome, AC = 2, AN = 251408, AF = 7.9552e-06); S>W (genome, AC = 1, AN = 31402, AF = 3.18451e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
107	G	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
108	F	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
109	H	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
110	Y	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
111	N	N>S; M>T	N>S (exome, AC = 5, AN = 251460, AF = 1.98839e-05); M>T (exome, AC = 12, AN = 251462, AF = 4.77209e-05); M>T (genome, AC = 1, AN = 31398, AF = 3.18492e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
112	V	V>F; V>I	V>F (exome, AC = 1, AN = 251458, AF = 3.97681e-06); V>I (genome, AC = 1, AN = 31408, AF = 3.1839e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
113	L	L>R	L>R (genome, AC = 1, AN = 31408, AF = 3.1839e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
114	S	S>T	S>T (exome, AC = 1, AN = 251438, AF = 3.97712e-06)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
115	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
116	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
117	G	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
118	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
119	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
120	G	G>A	G>A (exome, AC = 1, AN = 251426, AF = 3.97731e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
121	F	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
122	F	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
123	R	R>H	R>H (exome, AC = 5, AN = 251384, AF = 1.98899e-05); R>H (genome, AC = 1, AN = 31410, AF = 3.1837e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
124	R	R>H	R>H (exome, AC = 3, AN = 251360, AF = 1.19351e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
125	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
126	V	V>I	V>I (exome, AC = 5, AN = 251344, AF = 1.98931e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
127	I	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
128	K	K>Q	K>Q (exome, AC = 2, AN = 251358, AF = 7.95678e-06); K>Q (genome, AC = 2, AN = 31408, AF = 6.3678e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
129	G	G>R	G>R (exome, AC = 39, AN = 251336, AF = 0.000155171); G>R (genome, AC = 4, AN = 31408, AF = 0.000127356)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
130	A	A>T; A>V	A>T (exome, AC = 1, AN = 251292, AF = 3.97943e-06); A>V (exome, AC = 21, AN = 251216, AF = 8.35934e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
131	H	H>R	H>R (exome, AC = 3, AN = 251224, AF = 1.19415e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
132	Y	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
133	I	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
134	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
135	H	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
136	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
137	G	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
138	G	G>D	G>D (exome, AC = 12, AN = 250898, AF = 4.78282e-05); G>D (genome, AC = 5, AN = 31400, AF = 0.000159236)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
139	H	H>Y; H>R	H>Y (exome, AC = 2, AN = 250802, AF = 7.97442e-06); H>R (exome, AC = 3, AN = 250806, AF = 1.19614e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
140	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
141	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
142	M	M>V	M>V (exome, AC = 3, AN = 250482, AF = 1.19769e-05); M>V (genome, AC = 2, AN = 31404, AF = 6.36862e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
143	D	none	none	none	none	-	-1	-1	-	-	-	Negatively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
144	T	T>A; T>I	T>A (exome, AC = 1, AN = 250252, AF = 3.99597e-06); T>I (exome, AC = 1, AN = 250172, AF = 3.99725e-06)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
145	Y	none	none	none	none	-	-1	-1	-	-	-	Aromatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
146	M	M>L	M>L (exome, AC = 1, AN = 249702, AF = 4.00477e-06); M>L (genome, AC = 1, AN = 31400, AF = 3.18471e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
147	R	R>H; R>C	R>H (exome, AC = 1, AN = 249016, AF = 4.01581e-06); R>C (genome, AC = 1, AN = 31398, AF = 3.18492e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
148	R	R>C	R>C (exome, AC = 3, AN = 248818, AF = 1.2057e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
149	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
150	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
151	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
152	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
153	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
154	R	R>W	R>W (exome, AC = 1, AN = 243934, AF = 4.09947e-06); R>W (genome, AC = 2, AN = 31402, AF = 6.36902e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
155	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
156	R	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
157	K	K>R	K>R (exome, AC = 1, AN = 240138, AF = 4.16427e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
158	C	C>R	C>R (exome, AC = 2, AN = 239306, AF = 8.3575e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	C98-C118,C134-C158: NR C4-type	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding;zinc finger	-	-	-	-
159	R	R>C; R>H	R>C (exome, AC = 3, AN = 237446, AF = 1.26345e-05); R>H (exome, AC = 5, AN = 236962, AF = 2.11004e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
160	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
161	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
162	G	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
163	M	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
164	R	R>Q; R>W	R>Q (exome, AC = 3, AN = 223838, AF = 1.34026e-05); R>W (genome, AC = 1, AN = 31380, AF = 3.18674e-05); R>Q (genome, AC = 1, AN = 31402, AF = 3.18451e-05)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
165	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
166	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
167	C	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
168	V	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
169	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
170	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	N95-S170: Nuclear receptor	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	dna binding	-	-	-	-
171	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
172	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
173	Q	Q>R	Q>R (exome, AC = 4, AN = 251310, AF = 1.59166e-05)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
174	I	I>T	I>T (exome, AC = 1, AN = 251330, AF = 3.97883e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
175	R	R>C; R>H	R>C (exome, AC = 11, AN = 251322, AF = 4.37686e-05); R>H (exome, AC = 1, AN = 251346, AF = 3.97858e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
176	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
177	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
178	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
179	L	L>P	L>P (exome, AC = 6, AN = 251410, AF = 2.38654e-05); L>P (genome, AC = 1, AN = 31242, AF = 3.20082e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
180	K	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
181	R	R>W; R>Q	R>W (exome, AC = 4, AN = 251394, AF = 1.59113e-05); R>Q (exome, AC = 2, AN = 251402, AF = 7.95539e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
182	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
183	E	E>G	E>G (exome, AC = 2, AN = 251416, AF = 7.95494e-06)	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
184	E	none	none	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
185	E	E>K; E>D	E>K (exome, AC = 1, AN = 251404, AF = 3.97766e-06); E>D (exome, AC = 6, AN = 251420, AF = 2.38644e-05)	none	none	-	-1	-1	-	-	-	NegativelyCharged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
186	Q	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
187	A	A>S	A>S (exome, AC = 2, AN = 251412, AF = 7.95507e-06); A>S (genome, AC = 1, AN = 31356, AF = 3.18918e-05)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
188	H	H>N; H>R	H>N (exome, AC = 1, AN = 251408, AF = 3.9776e-06); H>R (exome, AC = 1, AN = 251416, AF = 3.97747e-06)	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
189	A	A>D	A>D (exome, AC = 1, AN = 251412, AF = 3.97753e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
190	T	T>I	T>I (exome, AC = 1, AN = 251418, AF = 3.97744e-06)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
191	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
192	L	L>W	L>W (exome, AC = 1, AN = 251400, AF = 3.97772e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
193	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
194	P	none	none	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
195	R	none	none	none	none	-	-1	-1	-	-	-	Positively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
196	A	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
197	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
198	S	none	none	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
199	P	P>S	P>S (exome, AC = 1, AN = 251014, AF = 3.98384e-06); P>S (genome, AC = 2, AN = 31336, AF = 6.38244e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
200	P	P>A; P>L	P>A (exome, AC = 1, AN = 251418, AF = 3.97744e-06); P>L (exome, AC = 3, AN = 251414, AF = 1.19325e-05)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
201	Q	Q>E; Q>H	Q>E (exome, AC = 1, AN = 251396, AF = 3.97779e-06); Q>H (exome, AC = 1, AN = 251412, AF = 3.97753e-06)	none	none	-	-1	-1	-	-	-	Neutral & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
202	I	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
203	L	none	none	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
204	P	P>T	P>T (exome, AC = 3, AN = 251420, AF = 1.19322e-05)	none	none	C:204:PRO-N/3.84-A:401:ARG;C:204:PRO-N/3.77-A:401:ARG;C:204:PRO-N/3.81-A:401:ARG	72.5	0.456	loop	coils	Medium-buried	Special	-	-	-	-	3ipu.A.413/25.461;5avi.A.413/25.946;5avi.C.413/26.081;5avl.A.413/25.98	3ipu.A.328/46.436;5avi.A.328/47.032;5avi.C.328/47.31;5avl.A.328/46.871	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
205	Q	none	none	none	none	B:205:GLN-N/3.27-A:401:ARG	195	0.867	loop	coils	exposed	Neutral & Polar	-	-	-	-	3ipq.A.413/28.195;3ips.A.413/28.689;3ips.B.413/28.235;3ipu.A.413/28.169;3ipu.B.413/28.009;5avi.A.413/28.33;5avi.C.413/28.168;5avl.A.413/28.394	3ipq.A.328/48.705;3ips.A.328/48.479;3ips.B.328/47.966;3ipu.A.328/47.952;3ipu.B.328/47.882;5avi.A.328/48.055;5avi.C.328/47.946;5avl.A.328/47.883	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
206	L	L>F	L>F (exome, AC = 1, AN = 251434, AF = 3.97719e-06)	none	none	-	26.5	0.132	loop	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/27.418;3ips.A.413/27.555;3ips.B.413/27.542;3ipu.A.413/27.301;3ipu.B.413/27.492;5avi.A.413/27.353;5avi.C.413/27.377;5avl.A.413/27.442	3ipq.A.328/46.62;3ips.A.328/46.052;3ips.B.328/45.913;3ipu.A.328/45.619;3ipu.B.328/45.932;5avi.A.328/45.748;5avi.C.328/45.828;5avl.A.328/45.655	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
207	S	none	none	none	none	-	34	0.21899999999999997	loop	coils	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/29.88;3ips.A.413/29.81;3ips.B.413/30.015;3ipu.A.413/29.76;3ipu.B.413/30.01;5avi.A.413/29.734;5avi.C.413/29.741;5avl.A.413/29.853;1uhl.B.413/30.164	3ipq.A.434/47.928;3ips.A.434/47.876;3ips.B.328/48.072;3ipu.A.328/47.543;3ipu.B.328/47.972;5avi.A.328/47.717;5avi.C.328/47.812;5avl.A.328/47.59;1uhl.B.434/46.914	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
208	P	P>L; P>R	P>L (exome, AC = 12, AN = 251418, AF = 4.77293e-05); P>R (genome, AC = 6, AN = 31384, AF = 0.00019118)	none	none	-	98	0.616	alpha-helix	Helices	Medium-exposed	Special	-	-	-	-	3ipq.A.413/31.691;3ips.A.413/31.745;3ips.B.413/31.891;3ipu.A.413/31.596;3ipu.B.413/31.799;5avi.A.413/31.592;5avi.C.413/31.592;5avl.A.413/31.841;1uhl.B.413/31.723	3ipq.A.434/47.826;3ips.A.434/47.834;3ips.B.434/48.154;3ipu.A.434/47.581;3ipu.B.434/47.98;5avi.A.328/47.801;5avi.C.328/47.886;5avl.A.434/47.894;1uhl.B.434/46.814	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
209	E	none	none	none	none	-	146	0.655	alpha-helix	Helices	Medium-exposed	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/30.136;3ips.A.413/29.933;3ips.B.413/30.131;3ipu.A.413/29.978;3ipu.B.413/30.117;5avi.A.413/30.026;5avi.C.413/30.033;5avl.A.413/30.051;1uhl.B.413/30.594	3ipq.A.434/45.295;3ips.A.434/45.118;3ips.B.434/45.429;3ipu.A.434/45.0;3ipu.B.434/45.318;5avi.A.434/45.488;5avi.C.434/45.332;5avl.A.434/45.233;1uhl.B.434/44.563	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
210	Q	none	none	none	none	-	35	0.156	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/26.57;3ips.A.413/26.474;3ips.B.413/26.575;3ipu.A.413/26.422;3ipu.B.413/26.52;5avi.A.413/26.467;5avi.C.413/26.508;5avl.A.413/26.566;1uhl.B.413/26.826	3ipq.A.434/42.972;3ips.A.434/42.947;3ips.B.434/43.102;3ipu.A.434/42.666;3ipu.B.434/42.939;5avi.A.434/43.135;5avi.C.434/43.188;5avl.A.434/42.943;1uhl.B.434/42.011	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
211	L	none	none	none	none	-	77	0.38299999999999995	alpha-helix	Helices	Medium-buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/27.249;3ips.A.306/27.668;3ips.B.306/27.884;3ipu.A.306/27.243;3ipu.B.306/27.437;5avi.A.306/27.515;5avi.C.306/27.439;5avl.A.306/27.474;1uhl.B.306/27.489	3ipq.A.434/43.507;3ips.A.328/43.499;3ips.B.328/43.422;3ipu.A.328/42.777;3ipu.B.328/43.005;5avi.A.328/43.036;5avi.C.328/43.097;5avl.A.328/42.99;1uhl.B.434/42.627	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
212	G	G>C	G>C (exome, AC = 2, AN = 251442, AF = 7.95412e-06)	none	none	-	28	0.24600000000000002	alpha-helix	Helices	buried	Special	-	-	-	-	3ipq.A.306/28.187;3ips.A.306/28.484;3ips.B.306/28.576;3ipu.A.306/28.22;3ipu.B.306/28.505;5avi.A.306/28.388;5avi.C.306/28.259;5avl.A.306/28.259;1uhl.B.306/28.299	3ipq.A.434/42.658;3ips.A.434/42.655;3ips.B.434/42.709;3ipu.A.434/42.548;3ipu.B.434/42.83;5avi.A.434/42.935;5avi.C.434/42.874;5avl.A.434/42.586;1uhl.B.434/41.949	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
213	M	M>V	M>V (exome, AC = 86, AN = 251444, AF = 0.000342024); M>V (genome, AC = 29, AN = 31376, AF = 0.000924273)	none	none	-	30	0.134	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/26.274;3ips.A.413/26.194;3ips.B.413/26.212;3ipu.A.413/26.318;3ipu.B.413/26.334;5avi.A.413/26.235;5avi.C.413/26.221;5avl.A.413/26.206;1uhl.B.413/26.66	3ipq.A.434/39.519;3ips.A.434/39.415;3ips.B.434/39.555;3ipu.A.434/39.4;3ipu.B.434/39.63;5avi.A.434/39.747;5avi.C.434/39.663;5avl.A.434/39.518;1uhl.B.434/38.854	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
214	I	none	none	none	none	-	7	0.036000000000000004	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/23.118;3ips.A.306/23.377;3ips.B.306/23.529;3ipu.A.306/23.116;3ipu.B.306/23.461;5avi.A.306/23.272;5avi.C.306/23.177;5avl.A.306/23.225;1uhl.B.306/23.491	3ipq.A.434/38.2;3ips.A.328/38.445;3ips.B.328/38.172;3ipu.A.328/37.799;3ipu.B.328/38.101;5avi.A.328/38.001;5avi.C.328/38.072;5avl.A.328/37.911;1uhl.B.434/37.519	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
215	E	E>K	E>K (exome, AC = 6, AN = 251438, AF = 2.38627e-05); E>K (genome, AC = 2, AN = 31380, AF = 6.37349e-05)	none	none	-	116	0.52	alpha-helix	Helices	Medium-exposed	NegativelyCharged & Polar	-	-	-	-	3ipq.A.306/23.397;3ips.A.306/23.701;3ips.B.306/23.923;3ipu.A.306/23.509;3ipu.B.306/23.754;5avi.A.306/23.534;5avi.C.306/23.459;5avl.A.306/23.65;1uhl.B.306/23.773	3ipq.A.434/39.097;3ips.A.328/38.717;3ips.B.328/38.652;3ipu.A.328/38.236;3ipu.B.328/38.455;5avi.A.328/38.285;5avi.C.328/38.35;5avl.A.328/38.38;1uhl.B.434/38.539	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
216	K	none	none	none	none	-	146	0.619	alpha-helix	Helices	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ipq.A.306/24.27;3ips.A.306/24.677;3ips.B.306/24.696;3ipu.A.306/24.56;3ipu.B.306/24.834;5avi.A.306/24.515;5avi.C.306/24.416;5avl.A.306/24.481;1uhl.B.306/24.778	3ipq.A.434/37.197;3ips.A.434/37.144;3ips.B.434/37.11;3ipu.A.434/37.124;3ipu.B.434/37.392;5avi.A.434/37.474;5avi.C.434/37.43;5avl.A.434/37.245;1uhl.B.434/36.795	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
217	L	none	none	none	none	-	3	0.015	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/21.271;3ips.A.306/21.42;3ips.B.306/21.58;3ipu.A.306/21.571;3ipu.B.306/21.822;5avi.A.306/21.322;5avi.C.306/21.22;5avl.A.306/21.331;1uhl.B.306/21.683	3ipq.A.434/33.998;3ips.A.434/34.031;3ips.B.434/34.169;3ipu.A.434/33.948;3ipu.B.434/34.153;5avi.A.434/34.324;5avi.C.434/34.344;5avl.A.434/34.021;1uhl.B.434/33.57	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
218	V	V>I	V>I (exome, AC = 2, AN = 251450, AF = 7.95387e-06); V>I (genome, AC = 1, AN = 31374, AF = 3.18735e-05)	none	none	-	28	0.161	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/18.922;3ips.A.306/19.316;3ips.B.306/19.476;3ipu.A.306/19.281;3ipu.B.306/19.52;5avi.A.306/19.207;5avi.C.306/19.107;5avl.A.306/19.118;1uhl.B.306/19.134	3ipq.A.328/34.349;3ips.A.328/33.791;3ips.B.328/33.678;3ipu.A.328/33.286;3ipu.B.328/33.466;5avi.A.328/33.381;5avi.C.328/33.437;5avl.A.328/33.214;1uhl.B.434/33.798	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
219	A	A>T; A>D	A>T (exome, AC = 2, AN = 251444, AF = 7.95406e-06); A>D (genome, AC = 1, AN = 31384, AF = 3.18634e-05)	none	none	-	65	0.504	alpha-helix	Helices	Medium-exposed	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/20.729;3ips.A.314/21.46;3ips.B.314/21.383;3ipu.A.314/21.386;3ipu.B.314/21.596;5avi.A.314/21.027;5avi.C.314/21.02;5avl.A.314/20.942;1uhl.B.306/21.172	3ipq.A.434/35.107;3ips.A.328/34.973;3ips.B.328/34.824;3ipu.A.328/34.594;3ipu.B.328/34.865;5avi.A.328/34.508;5avi.C.328/34.557;5avl.A.328/34.448;1uhl.B.434/34.342	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
220	A	A>S	A>S (exome, AC = 3, AN = 251452, AF = 1.19307e-05); A>S (genome, AC = 3, AN = 31378, AF = 9.56084e-05)	none	none	-	25	0.19399999999999998	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/20.164;3ips.A.314/20.985;3ips.B.314/20.993;3ipu.A.314/21.357;3ipu.B.314/21.478;5avi.A.314/20.394;5avi.C.314/20.378;5avl.A.314/20.564;1uhl.B.314/21.18	3ipq.A.434/31.99;3ips.A.434/32.053;3ips.B.434/32.064;3ipu.A.434/32.18;3ipu.B.434/32.453;5avi.A.434/32.239;5avi.C.434/32.232;5avl.A.434/32.049;1uhl.B.434/31.467	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
221	Q	none	none	none	none	-	47	0.209	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.314/16.414;3ips.B.314/17.202;3ipu.A.314/17.677;3ipu.B.314/17.764;5avi.A.314/16.625;5avi.C.314/16.596;5avl.A.314/16.79;1uhl.B.314/17.546	3ipq.A.434/29.826;3ips.B.328/29.649;3ipu.A.328/29.686;3ipu.B.328/29.824;5avi.A.328/29.282;5avi.C.328/29.345;5avl.A.328/29.37;1uhl.B.434/29.046	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
222	Q	Q>K; Q>H	Q>K (exome, AC = 1, AN = 251442, AF = 3.97706e-06); Q>H (exome, AC = 1, AN = 251452, AF = 3.9769e-06)	none	none	-	164	0.7290000000000001	loop	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ipq.A.314/16.036;3ips.A.314/16.608;3ips.B.314/16.542;3ipu.A.314/17.038;3ipu.B.314/17.094;5avi.A.314/16.544;5avi.C.314/16.419;5avl.A.314/17.246;1uhl.B.314/16.619	3ipq.A.328/31.181;3ips.A.328/30.33;3ips.B.328/30.255;3ipu.A.328/30.102;3ipu.B.328/30.176;5avi.A.328/30.074;5avi.C.328/30.228;5avl.A.328/30.661;1uhl.B.328/30.874	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
223	Q	none	none	none	none	-	87	0.387	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipu.A.314/19.757;1uhl.B.314/17.849	3ipu.A.434/31.26;1uhl.B.434/30.334	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
224	C	C>Y	C>Y (exome, AC = 1, AN = 251452, AF = 3.9769e-06)	none	none	-	3	0.018000000000000002	alpha-helix	Helices	core	Special	-	-	-	-	3ipu.A.314/18.448;3ipu.B.314/18.421;1uhl.B.314/17.208	3ipu.A.434/27.572;3ipu.B.434/27.768;1uhl.B.434/26.867	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
225	N	N>K	N>K (exome, AC = 1, AN = 251436, AF = 3.97716e-06)	none	none	-	47	0.24100000000000002	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipu.A.314/15.093;3ipu.B.314/15.059;1uhl.B.314/13.554	3ipu.A.328/26.348;3ipu.B.328/26.498;1uhl.B.434/26.4	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
226	R	R>W; R>Q	R>W (exome, AC = 2, AN = 251436, AF = 7.95431e-06); R>Q (exome, AC = 1, AN = 251422, AF = 3.97738e-06)	none	none	-	147	0.536	alpha-helix	Helices	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ipu.A.314/17.147;3ipu.B.314/17.409;1uhl.B.314/14.059	3ipu.A.328/28.445;3ipu.B.328/28.759;1uhl.B.434/26.75	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
227	R	R>C; R>L	R>C (exome, AC = 3, AN = 251406, AF = 1.19329e-05); R>L (exome, AC = 1, AN = 251426, AF = 3.97731e-06); R>C (genome, AC = 1, AN = 31368, AF = 3.18796e-05)	none	none	-	118	0.431	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipu.A.314/19.446;3ipu.B.314/19.574;1uhl.B.314/16.183	3ipu.A.434/27.274;3ipu.B.434/27.512;1uhl.B.434/25.566	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
228	S	none	none	none	none	-	6	0.039	turn	coils	core	Neutral & Polar	-	-	-	-	3ipu.A.314/16.863;3ipu.B.314/16.925;1uhl.B.314/13.604	3ipu.A.434/23.886;3ipu.B.434/24.115;1uhl.B.328/24.234	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
229	F	none	none	none	none	-	126	0.525	alpha-helix	Helices	Medium-exposed	Aromatic & Hydrophobic	-	-	-	-	3ipu.A.314/15.712;3ipu.B.314/15.508;1uhl.B.314/13.657	3ipu.A.328/25.014;3ipu.B.328/24.908;1uhl.B.434/21.109	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
230	S	none	none	none	none	-	53	0.342	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipu.A.314/18.209;3ipu.B.314/17.977	3ipu.A.434/24.838;3ipu.B.434/25.139	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
231	D	D>N	D>N (genome, AC = 1, AN = 31380, AF = 3.18674e-05)	none	none	-	66	0.342	alpha-helix	Helices	Medium-buried	Negatively Charged & Polar	-	-	-	-	3ipu.A.314/17.789;3ipu.B.314/17.327	3ipu.A.434/21.152;3ipu.B.434/21.399	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
232	R	R>Q	R>Q (exome, AC = 4, AN = 251332, AF = 1.59152e-05)	none	none	-	47.5	0.17300000000000001	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipu.A.314/14.041;3ipu.B.314/13.62	3ipu.A.328/20.368;3ipu.B.328/20.101	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
233	L	none	none	none	none	-	164	0.816	loop	coils	exposed	Aliphatic & Hydrophobic	-	-	-	-	3ips.B.314/16.154;3ipu.A.314/15.399;3ipu.B.314/15.165	3ips.B.434/22.503;3ipu.A.328/21.327;3ipu.B.328/21.257	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
234	R	R>G; R>Q	R>G (exome, AC = 2, AN = 251308, AF = 7.95836e-06); R>Q (exome, AC = 5, AN = 251314, AF = 1.98954e-05)	none	none	-	242	0.883	loop	coils	exposed	Positively Charged & Polar	-	-	-	-	3ips.B.314/17.656;3ipu.A.314/17.616;3ipu.B.314/17.689;5avi.A.314/16.769;5avi.C.314/16.919	3ips.B.434/19.777;3ipu.A.434/20.225;3ipu.B.328/20.851;5avi.A.328/21.116;5avi.C.328/20.903	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
235	V	none	none	none	none	-	25	0.14400000000000002	loop	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ips.A.314/15.136;3ips.B.314/15.305;3ipu.A.314/15.272;3ipu.B.314/15.479;5avi.A.314/14.825;5avi.C.314/15.19;5avl.A.314/15.66	3ips.A.328/17.341;3ips.B.328/17.133;3ipu.A.328/16.901;3ipu.B.328/17.204;5avi.A.328/17.4;5avi.C.328/17.196;5avl.A.328/17.954	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
236	T	T>M	T>M (exome, AC = 4, AN = 251240, AF = 1.5921e-05)	none	none	-	42	0.244	loop	coils	buried	Neutral & Polar	-	-	-	-	3ipq.A.314/16.368;3ips.A.314/16.17;3ips.B.314/16.616;3ipu.A.246/16.479;3ipu.B.314/16.435;5avi.A.314/16.227;5avi.C.314/16.199;5avl.A.314/16.632	3ipq.A.434/15.509;3ips.A.328/14.986;3ips.B.328/15.053;3ipu.A.328/15.106;3ipu.B.328/14.924;5avi.A.328/15.343;5avi.C.328/14.725;5avl.A.328/15.989	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
237	P	none	none	none	none	-	95	0.597	loop	coils	Medium-exposed	Special	-	-	-	-	3ipq.A.314/15.004;3ips.A.314/14.101;3ips.B.314/14.448;3ipu.A.314/14.915;3ipu.B.314/14.489;5avi.A.314/14.429;5avi.C.314/15.092;5avl.A.314/15.728	3ipq.A.328/14.651;3ips.A.328/13.893;3ips.B.328/13.942;3ipu.A.328/14.043;3ipu.B.328/13.84;5avi.A.328/14.041;5avi.C.328/13.873;5avl.A.328/14.409	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
238	W	none	none	none	none	-	65.5	0.23	loop	coils	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.314/13.282;3ips.A.314/13.084;3ips.B.314/13.159;3ipu.A.314/13.238;3ipu.B.314/13.157;5avi.A.314/13.068;5avi.C.314/13.396;5avl.A.314/13.786	3ipq.A.328/11.335;3ips.A.328/10.729;3ips.B.328/10.769;3ipu.A.328/10.666;3ipu.B.328/10.514;5avi.A.328/10.715;5avi.C.328/10.637;5avl.A.328/10.926	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
239	P	none	none	none	none	-	79	0.49700000000000005	loop	coils	Medium-buried	Special	-	-	-	-	3ipq.A.314/16.347;3ips.A.246/10.712;3ips.B.246/11.318;3ipu.A.246/10.872;3ipu.B.246/10.702;5avi.A.246/11.646;5avi.C.246/11.023	3ipq.A.328/10.763;3ips.A.328/10.597;3ips.B.328/10.844;3ipu.A.328/10.719;3ipu.B.328/10.486;5avi.A.328/11.287;5avi.C.328/10.59	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
240	M	M>V	M>V (exome, AC = 1, AN = 251338, AF = 3.97871e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
241	A	A>T	A>T (exome, AC = 1, AN = 251338, AF = 3.97871e-06)	none	none	-	-1	-1	-	-	-	Aliphatic & Hydrophobic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
242	P	P>S	P>S (exome, AC = 1, AN = 251346, AF = 3.97858e-06)	none	none	-	-1	-1	-	-	-	Special	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
243	D	D>E	D>E (exome, AC = 1, AN = 251366, AF = 3.97826e-06)	none	none	-	-1	-1	-	-	-	Negatively Charged & Polar	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
244	P	none	none	none	none	-	143	0.899	loop	coils	exposed	Special	-	-	-	-	3ipu.A.246/6.281;5avi.A.246/6.139	3ipu.A.328/10.827;5avi.A.328/12.086	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
245	H	H>Y; H>R	H>Y (exome, AC = 1, AN = 251364, AF = 3.97829e-06); H>R (exome, AC = 6, AN = 251392, AF = 2.38671e-05)	none	none	-	164	0.732	loop	coils	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ipu.A.246/3.821;5avi.A.246/3.816	3ipu.A.328/9.946;5avi.A.328/9.584	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
246	S	none	none	none	none	-	109	0.703	loop	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ips.A.246/0.0;3ips.B.246/0.0;3ipu.A.246/0.0;3ipu.B.246/0.0;5avi.A.246/0.0;5avi.C.246/0.0	3ips.A.328/10.899;3ips.B.328/11.096;3ipu.A.328/11.1;3ipu.B.328/11.348;5avi.A.328/11.289;5avi.C.328/11.217	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
247	R	R>W; R>Q	R>W (exome, AC = 8, AN = 251382, AF = 3.18241e-05); R>Q (exome, AC = 3, AN = 251388, AF = 1.19337e-05); R>W (genome, AC = 4, AN = 31394, AF = 0.000127413)	none	none	-	177	0.6459999999999999	alpha-helix	Helices	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ips.A.246/3.825;3ips.B.246/3.85;3ipu.A.246/3.818;3ipu.B.246/3.81;5avi.A.246/3.83;5avi.C.246/3.815;5avl.A.312/24.35	3ips.A.328/10.894;3ips.B.328/11.158;3ipu.A.328/11.083;3ipu.B.328/11.572;5avi.A.328/11.987;5avi.C.328/11.096;5avl.A.328/11.04	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
248	E	none	none	none	none	-	144	0.6459999999999999	alpha-helix	Helices	Medium-exposed	NegativelyCharged & Polar	-	-	-	-	3ipq.A.314/23.649;3ips.A.246/5.542;3ips.B.246/5.535;3ipu.A.246/5.147;3ipu.B.246/5.477;5avi.A.246/5.46;5avi.C.246/5.516;5avl.A.312/24.542;1uhl.B.312/22.542	3ipq.A.328/10.358;3ips.A.328/11.583;3ips.B.328/12.009;3ipu.A.328/11.981;3ipu.B.328/12.345;5avi.A.328/12.285;5avi.C.328/11.941;5avl.A.328/11.985;1uhl.B.328/9.263	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
249	A	none	none	none	none	-	17	0.132	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/20.728;3ips.A.246/5.018;3ips.B.246/5.751;3ipu.A.246/5.186;3ipu.B.246/5.461;5avi.A.246/5.085;5avi.C.246/5.637;5avl.A.312/21.175;1uhl.B.314/24.271	3ipq.A.328/9.111;3ips.A.328/8.804;3ips.B.328/9.316;3ipu.A.328/9.084;3ipu.B.328/9.383;5avi.A.328/9.069;5avi.C.328/9.135;5avl.A.328/9.475;1uhl.B.328/11.466	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
250	R	R>H; R>P	R>H (exome, AC = 9, AN = 251410, AF = 3.57981e-05); R>P (genome, AC = 1, AN = 31400, AF = 3.18471e-05)	none	none	-	125	0.456	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.312/19.166;3ips.A.246/6.594;3ips.B.246/6.284;3ipu.A.246/6.546;3ipu.B.246/6.243;5avi.A.246/6.493;5avi.C.246/6.589;5avl.A.312/19.931;1uhl.B.314/20.476	3ipq.A.328/6.101;3ips.A.328/6.427;3ips.B.328/6.799;3ipu.A.328/6.529;3ipu.B.328/6.94;5avi.A.328/6.739;5avi.C.328/6.719;5avl.A.328/6.96;1uhl.B.328/8.693	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
251	Q	none	none	none	none	-	86	0.382	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.314/19.875;3ips.A.246/8.962;3ips.B.246/8.851;3ipu.A.246/8.78;3ipu.B.246/8.639;5avi.A.246/8.662;5avi.C.246/9.155;5avl.A.314/21.423;1uhl.B.314/20.673	3ipq.A.328/9.083;3ips.A.328/9.352;3ips.B.328/9.425;3ipu.A.328/9.483;3ipu.B.328/9.687;5avi.A.328/9.688;5avi.C.328/9.416;5avl.A.328/9.518;1uhl.B.328/8.556	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
252	Q	none	none	none	none	-	76	0.33799999999999997	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.314/18.19;3ips.A.246/10.254;3ips.B.246/10.267;3ipu.A.246/10.104;3ipu.B.246/10.069;5avi.A.246/10.146;5avi.C.246/10.31;5avl.A.314/19.465;1uhl.B.314/18.896	3ipq.A.328/10.241;3ips.A.328/10.031;3ips.B.328/9.977;3ipu.A.328/10.044;3ipu.B.328/10.133;5avi.A.328/10.115;5avi.C.328/9.846;5avl.A.328/10.213;1uhl.B.328/10.17	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
253	R	R>H	R>H (exome, AC = 1, AN = 251424, AF = 3.97735e-06)	none	none	-	51	0.18600000000000003	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.314/14.959;3ips.A.246/11.092;3ips.B.246/11.234;3ipu.A.246/11.082;3ipu.B.246/11.049;5avi.A.246/10.972;5avi.C.246/11.189;5avl.A.314/16.155;1uhl.B.314/15.722	3ipq.A.328/7.488;3ips.A.328/6.979;3ips.B.328/6.968;3ipu.A.328/6.97;3ipu.B.328/6.958;5avi.A.328/6.866;5avi.C.328/6.7;5avl.A.328/6.993;1uhl.B.328/6.947	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
254	F	none	none	none	none	-	20	0.083	alpha-helix	Helices	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.314/16.048;3ips.A.246/12.887;3ips.B.246/12.829;3ipu.A.246/12.604;3ipu.B.246/12.674;5avi.A.246/12.611;5avi.C.246/13.037;5avl.A.314/16.951;1uhl.B.314/16.399	3ipq.A.328/8.648;3ips.A.328/7.917;3ips.B.328/7.871;3ipu.A.328/7.829;3ipu.B.328/7.891;5avi.A.328/7.941;5avi.C.328/7.809;5avl.A.328/7.65;1uhl.B.328/7.699	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
255	A	none	none	none	none	-	23	0.17800000000000002	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/16.796;3ips.A.246/14.468;3ips.B.246/14.432;3ipu.A.246/14.16;3ipu.B.246/14.282;5avi.A.246/14.22;5avi.C.246/14.63;5avl.A.314/17.728;1uhl.B.314/17.479	3ipq.A.434/9.464;3ips.A.434/9.786;3ips.B.434/9.735;3ipu.A.434/10.208;3ipu.B.434/10.575;5avi.A.434/10.414;5avi.C.434/10.045;5avl.A.434/9.692;1uhl.B.434/9.906	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
256	H	H>Y	H>Y (exome, AC = 1, AN = 251428, AF = 3.97728e-06)	none	none	-	7	0.031	alpha-helix	Helices	core	Positively Charged & Polar	-	-	-	-	3ipq.A.314/13.443;3ips.A.314/13.924;3ips.B.314/13.956;3ipu.A.314/13.937;3ipu.B.314/13.847;5avi.A.314/13.728;5avi.C.314/13.948;5avl.A.314/14.488;1uhl.B.314/13.947	3ipq.A.328/12.015;3ips.A.328/11.17;3ips.B.328/11.072;3ipu.A.328/11.055;3ipu.B.328/10.912;5avi.A.328/11.042;5avi.C.328/11.02;5avl.A.328/11.252;1uhl.B.328/10.888	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
257	F	none	none	none	none	-	27	0.113	alpha-helix	Helices	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.314/11.781;3ips.A.314/12.563;3ips.B.314/12.721;3ipu.A.314/12.393;3ipu.B.314/12.468;5avi.A.314/12.402;5avi.C.314/12.408;5avl.A.314/12.775;1uhl.B.314/12.553	3ipq.A.328/11.224;3ips.A.328/10.041;3ips.B.328/10.056;3ipu.A.328/10.086;3ipu.B.328/10.045;5avi.A.328/10.005;5avi.C.328/9.959;5avl.A.328/10.066;1uhl.B.328/10.398	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
258	T	none	none	none	none	-	17	0.099	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.314/14.827;3ips.A.314/15.508;3ips.B.314/15.76;3ipu.A.314/15.445;3ipu.B.314/15.518;5avi.A.314/15.399;5avi.C.314/15.317;5avl.A.314/15.647;1uhl.B.314/15.578	3ipq.A.434/9.762;3ips.A.434/9.937;3ips.B.434/9.939;3ipu.A.434/10.266;3ipu.B.434/10.421;5avi.A.434/10.406;5avi.C.434/10.314;5avl.A.434/10.165;1uhl.B.434/9.614	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
259	E	none	none	none	none	-	61	0.27399999999999997	alpha-helix	Helices	Medium-buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.314/14.541;3ips.A.314/15.255;3ips.B.314/15.313;3ipu.A.314/15.275;3ipu.B.314/15.491;5avi.A.314/15.239;5avi.C.314/15.062;5avl.A.314/15.427;1uhl.B.314/14.935	3ipq.A.434/12.203;3ips.A.434/12.319;3ips.B.434/12.52;3ipu.A.434/12.811;3ipu.B.434/12.963;5avi.A.434/13.025;5avi.C.434/12.93;5avl.A.434/12.749;1uhl.B.434/12.631	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
260	L	none	none	none	none	-	21	0.10400000000000001	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/11.087;3ips.A.314/11.768;3ips.B.314/11.945;3ipu.A.314/11.878;3ipu.B.314/12.061;5avi.A.314/11.759;5avi.C.314/11.592;5avl.A.314/12.071;1uhl.B.314/11.645	3ipq.A.434/15.084;3ips.A.328/14.978;3ips.B.328/15.038;3ipu.A.328/15.015;3ipu.B.328/15.098;5avi.A.328/14.984;5avi.C.328/14.871;5avl.A.328/15.065;1uhl.B.434/14.574	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
261	A	none	none	none	none	-	16	0.124	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/12.789;3ips.A.314/13.728;3ips.B.314/14.015;3ipu.A.314/13.855;3ipu.B.314/13.947;5avi.A.314/13.809;5avi.C.314/13.66;5avl.A.314/13.935;1uhl.B.314/13.474	3ipq.A.434/13.751;3ips.A.434/13.974;3ips.B.434/13.902;3ipu.A.434/14.028;3ipu.B.434/14.044;5avi.A.434/14.177;5avi.C.434/14.116;5avl.A.434/14.053;1uhl.B.434/12.917	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
262	I	none	none	none	none	-	37	0.188	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/15.675;3ips.A.314/16.599;3ips.B.314/16.765;3ipu.A.314/16.89;3ipu.B.314/16.992;5avi.A.314/16.721;5avi.C.314/16.54;5avl.A.314/16.919;1uhl.B.314/16.134	3ipq.A.434/13.727;3ips.A.434/13.783;3ips.B.434/13.902;3ipu.A.434/13.825;3ipu.B.434/13.942;5avi.A.434/14.24;5avi.C.434/14.14;5avl.A.434/13.915;1uhl.B.434/13.214	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
263	V	V>I	V>I (exome, AC = 2, AN = 251440, AF = 7.95418e-06)	none	none	-	39	0.22399999999999998	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/13.811;3ips.A.314/14.653;3ips.B.314/14.862;3ipu.A.314/15.478;3ipu.B.314/15.538;5avi.A.314/14.91;5avi.C.314/14.681;5avl.A.314/15.217;1uhl.B.314/14.048	3ipq.A.434/17.276;3ips.A.434/17.385;3ips.B.434/17.449;3ipu.A.434/17.512;3ipu.B.434/17.588;5avi.A.434/17.85;5avi.C.434/17.765;5avl.A.434/17.478;1uhl.B.434/16.851	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
264	S	none	none	none	none	-	23	0.14800000000000002	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.314/12.76;3ips.A.314/13.746;3ips.B.314/14.005;3ipu.A.314/14.019;3ipu.B.314/14.064;5avi.A.314/13.851;5avi.C.314/13.697;5avl.A.314/14.031;1uhl.B.314/13.483	3ipq.A.434/18.241;3ips.A.434/18.401;3ips.B.434/18.483;3ipu.A.434/18.421;3ipu.B.434/18.417;5avi.A.434/18.643;5avi.C.434/18.556;5avl.A.434/18.337;1uhl.B.434/17.373	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
265	V	none	none	none	none	-	4	0.023	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/16.429;3ips.A.314/17.458;3ips.B.314/17.686;3ipu.A.314/17.658;3ipu.B.314/17.665;5avi.A.314/17.563;5avi.C.314/17.457;5avl.A.314/17.696;1uhl.B.314/17.108	3ipq.A.434/17.203;3ips.A.434/17.371;3ips.B.434/17.514;3ipu.A.434/17.507;3ipu.B.434/17.344;5avi.A.434/17.77;5avi.C.434/17.765;5avl.A.434/17.472;1uhl.B.434/15.846	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
266	Q	none	none	none	none	-	80	0.35600000000000004	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.314/17.795;3ips.A.314/18.671;3ips.B.314/18.996;3ipu.A.314/19.012;3ipu.B.314/19.134;5avi.A.314/18.829;5avi.C.314/18.593;5avl.A.314/18.928;1uhl.B.314/18.086	3ipq.A.434/19.237;3ips.A.434/19.454;3ips.B.434/19.407;3ipu.A.434/19.63;3ipu.B.434/19.567;5avi.A.434/20.072;5avi.C.434/20.064;5avl.A.434/19.882;1uhl.B.434/18.322	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
267	E	none	none	none	none	-	104	0.466	alpha-helix	Helices	Medium-buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.314/16.081;3ips.A.314/16.732;3ips.B.314/16.905;3ipu.A.314/17.235;3ipu.B.314/17.306;5avi.A.314/16.781;5avi.C.314/16.624;5avl.A.314/16.907;1uhl.B.314/16.345	3ipq.A.434/22.099;3ips.A.434/22.188;3ips.B.434/22.109;3ipu.A.434/22.402;3ipu.B.434/22.414;5avi.A.434/22.639;5avi.C.434/22.665;5avl.A.434/22.446;1uhl.B.434/21.157	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
268	I	I>T	I>T (exome, AC = 2, AN = 251428, AF = 7.95456e-06)	none	none	-	8	0.040999999999999995	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/17.408;3ips.A.314/18.173;3ips.B.314/18.346;3ipu.A.314/18.352;3ipu.B.314/18.424;5avi.A.314/18.024;5avi.C.314/17.87;5avl.A.314/18.204;1uhl.B.314/17.903	3ipq.A.434/22.017;3ips.A.434/22.317;3ips.B.434/22.206;3ipu.A.434/22.148;3ipu.B.434/22.264;5avi.A.434/22.394;5avi.C.434/22.366;5avl.A.434/22.339;1uhl.B.434/20.703	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
269	V	V>L	V>L (exome, AC = 3, AN = 251424, AF = 1.1932e-05)	none	none	-	2	0.011000000000000001	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/20.815;3ips.A.314/21.574;3ips.B.314/21.8;3ipu.A.314/21.877;3ipu.B.314/21.909;5avi.A.314/21.594;5avi.C.314/21.419;5avl.A.314/21.722;1uhl.B.314/21.359	3ipq.A.434/22.475;3ips.A.434/22.635;3ips.B.434/22.7;3ipu.A.434/22.61;3ipu.B.434/22.56;5avi.A.434/23.071;5avi.C.434/23.079;5avl.A.434/22.943;1uhl.B.434/21.211	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
270	D	D>G	D>G (exome, AC = 1, AN = 251416, AF = 3.97747e-06)	none	none	-	77	0.39899999999999997	alpha-helix	Helices	Medium-buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.314/20.8;3ips.A.314/21.572;3ips.B.314/21.943;3ipu.A.314/22.005;3ipu.B.314/22.022;5avi.A.314/21.5;5avi.C.314/21.301;5avl.A.314/21.671;1uhl.B.314/20.82	3ipq.A.434/25.187;3ips.A.434/25.548;3ips.B.434/25.565;3ipu.A.434/25.394;3ipu.B.434/25.401;5avi.A.434/25.913;5avi.C.434/25.909;5avl.A.434/25.761;1uhl.B.434/23.791	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
271	F	none	none	none	none	-	9	0.037000000000000005	alpha-helix	Helices	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.314/20.103;3ips.A.314/20.619;3ips.B.314/20.726;3ipu.A.314/21.039;3ipu.B.314/20.95;5avi.A.314/20.377;5avi.C.314/20.281;5avl.A.314/20.536;1uhl.B.314/20.304	3ipq.A.434/26.972;3ips.A.434/27.29;3ips.B.434/27.042;3ipu.A.434/27.156;3ipu.B.434/27.058;5avi.A.434/27.358;5avi.C.434/27.416;5avl.A.434/27.106;1uhl.B.434/25.544	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
272	A	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/21.38;3ips.A.413/21.799;3ips.B.413/21.83;3ipu.A.413/21.861;3ipu.B.413/21.78;5avi.A.413/21.865;5avi.C.413/21.73;5avl.A.413/21.869;1uhl.B.413/21.604	3ipq.A.434/26.882;3ips.A.434/27.103;3ips.B.434/27.112;3ipu.A.434/27.045;3ipu.B.434/26.999;5avi.A.434/27.316;5avi.C.434/27.291;5avl.A.434/27.142;1uhl.B.434/25.353	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
273	K	none	none	none	none	-	42	0.17800000000000002	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/25.149;3ips.A.413/25.575;3ips.B.413/25.566;3ipu.A.413/25.639;3ipu.B.413/25.546;5avi.A.413/25.679;5avi.C.413/25.531;5avl.A.413/25.64;1uhl.B.413/25.331	3ipq.A.434/28.577;3ips.A.434/28.833;3ips.B.434/28.789;3ipu.A.434/28.783;3ipu.B.434/28.774;5avi.A.434/29.248;5avi.C.434/29.113;5avl.A.434/28.882;1uhl.B.434/26.932	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
274	Q	none	none	none	none	-	106	0.47100000000000003	turn	coils	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.314/24.921;3ips.A.314/25.703;3ips.B.314/25.592;3ipu.A.314/26.006;3ipu.B.413/25.846;5avi.A.314/25.288;5avi.C.314/25.519;5avl.A.314/25.502;1uhl.B.314/25.394	3ipq.A.434/31.303;3ips.A.434/31.76;3ips.B.434/31.575;3ipu.A.434/31.633;3ipu.B.434/31.521;5avi.A.434/31.973;5avi.C.434/32.059;5avl.A.434/31.656;1uhl.B.434/29.886	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
275	L	L>R	L>R (exome, AC = 1, AN = 251412, AF = 3.97753e-06)	none	none	-	4	0.02	bend	coils	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/23.177;3ips.A.413/23.624;3ips.B.413/23.355;3ipu.A.413/23.546;3ipu.B.413/23.452;5avi.A.413/23.564;5avi.C.413/23.519;5avl.A.413/23.454;1uhl.B.413/23.832	3ipq.A.434/32.005;3ips.A.434/32.37;3ips.B.434/32.07;3ipu.A.434/32.024;3ipu.B.434/31.977;5avi.A.434/32.466;5avi.C.434/32.554;5avl.A.434/32.095;1uhl.B.434/30.569	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
276	P	none	none	none	none	-	67	0.42100000000000004	turn	coils	Medium-buried	Special	-	-	-	-	3ipq.A.413/25.486;3ips.A.413/25.84;3ips.B.413/25.659;3ipu.A.413/25.778;3ipu.B.413/25.788;5avi.A.413/25.772;5avi.C.413/25.723;5avl.A.413/25.684;1uhl.B.413/26.26	3ipq.A.434/35.322;3ips.A.434/35.535;3ips.B.434/35.495;3ipu.A.434/35.307;3ipu.B.434/35.266;5avi.A.434/35.66;5avi.C.434/35.705;5avl.A.434/35.342;1uhl.B.434/33.865	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
277	G	none	none	none	none	-	14	0.12300000000000001	turn	coils	buried	Special	-	-	-	-	3ipq.A.413/25.61;3ips.A.413/25.891;3ips.B.413/25.62;3ipu.A.413/26.09;3ipu.B.413/26.103;5avi.A.413/25.785;5avi.C.413/25.842;5avl.A.413/25.807;1uhl.B.413/26.04	3ipq.A.434/34.885;3ips.A.434/34.973;3ips.B.434/34.985;3ipu.A.434/34.88;3ipu.B.434/34.791;5avi.A.434/35.111;5avi.C.434/35.161;5avl.A.434/34.89;1uhl.B.434/32.81	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
278	F	none	none	none	none	-	0	0	turn	coils	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/24.144;3ips.A.413/24.354;3ips.B.413/24.232;3ipu.A.413/24.338;3ipu.B.413/24.382;5avi.A.413/24.384;5avi.C.413/24.345;5avl.A.413/24.359;1uhl.B.413/24.538	3ipq.A.434/31.166;3ips.A.434/31.246;3ips.B.434/31.297;3ipu.A.434/31.107;3ipu.B.434/31.003;5avi.A.434/31.417;5avi.C.434/31.435;5avl.A.434/31.197;1uhl.B.434/29.127	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
279	L	none	none	none	none	-	76	0.37799999999999995	turn	coils	Medium-buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/27.532;3ips.A.413/27.65;3ips.B.413/27.506;3ipu.A.413/27.739;3ipu.B.413/27.76;5avi.A.413/27.756;5avi.C.413/27.722;5avl.A.413/27.737;1uhl.B.413/27.915	3ipq.A.434/31.556;3ips.A.434/31.537;3ips.B.434/31.564;3ipu.A.434/31.542;3ipu.B.434/31.445;5avi.A.434/31.822;5avi.C.434/31.841;5avl.A.434/31.562;1uhl.B.434/29.581	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
280	Q	Q>L; Q>H	Q>L (exome, AC = 2, AN = 251366, AF = 7.95653e-06); Q>H (exome, AC = 1, AN = 251340, AF = 3.97867e-06)	none	none	-	154	0.684	turn	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ipq.A.413/28.94;3ips.A.413/29.111;3ips.B.413/28.931;3ipu.A.413/29.222;3ipu.B.413/29.201;5avi.A.413/29.213;5avi.C.413/29.2;5avl.A.413/29.102;1uhl.B.413/29.036	3ipq.A.434/34.401;3ips.A.434/34.416;3ips.B.434/34.43;3ipu.A.434/34.332;3ipu.B.434/34.174;5avi.A.434/34.747;5avi.C.434/34.719;5avl.A.434/34.394;1uhl.B.434/32.283	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
281	L	none	none	none	none	-	10	0.05	bend	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/26.65;3ips.A.413/26.765;3ips.B.413/26.502;3ipu.A.413/26.902;3ipu.B.413/26.814;5avi.A.413/26.896;5avi.C.413/26.907;5avl.A.413/26.838;1uhl.B.413/26.997	3ipq.A.434/32.126;3ips.A.434/32.026;3ips.B.434/32.12;3ipu.A.434/31.928;3ipu.B.434/31.799;5avi.A.434/32.408;5avi.C.434/32.341;5avl.A.434/32.073;1uhl.B.434/30.128	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
282	S	none	none	none	none	-	49	0.316	loop	coils	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/28.354;3ips.A.413/28.389;3ips.B.413/28.351;3ipu.A.413/28.623;3ipu.B.413/28.411;5avi.A.413/28.366;5avi.C.413/28.324;5avl.A.413/28.55;1uhl.B.413/28.389	3ipq.A.434/30.834;3ips.A.434/30.742;3ips.B.434/31.002;3ipu.A.434/30.627;3ipu.B.434/30.401;5avi.A.434/30.804;5avi.C.434/30.662;5avl.A.434/30.745;1uhl.B.434/28.668	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
283	R	R>Q	R>Q (exome, AC = 15, AN = 251290, AF = 5.9692e-05); R>Q (genome, AC = 2, AN = 31400, AF = 6.36943e-05)	none	none	-	81	0.29600000000000004	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/27.904;3ips.A.413/27.993;3ips.B.413/27.955;3ipu.A.413/28.11;3ipu.B.413/27.962;5avi.A.413/28.042;5avi.C.413/27.859;5avl.A.413/28.03;1uhl.B.413/27.431	3ipq.A.434/27.612;3ips.A.434/27.571;3ips.B.434/27.774;3ipu.A.434/27.4;3ipu.B.434/27.216;5avi.A.434/27.594;5avi.C.434/27.417;5avl.A.434/27.547;1uhl.B.434/25.457	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
284	E	none	none	none	none	-	55	0.247	alpha-helix	Helices	buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/26.531;3ips.A.413/26.682;3ips.B.413/26.451;3ipu.A.413/26.869;3ipu.B.413/26.64;5avi.A.413/26.64;5avi.C.413/26.622;5avl.A.413/26.683;1uhl.B.413/25.961	3ipq.A.434/26.26;3ips.A.434/26.104;3ips.B.434/26.254;3ipu.A.434/26.086;3ipu.B.434/25.883;5avi.A.434/26.112;5avi.C.434/26.001;5avl.A.434/26.057;1uhl.B.434/23.462	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
285	D	none	none	none	none	-	2	0.01	alpha-helix	Helices	core	Negatively Charged & Polar	-	-	-	-	3ipq.A.413/23.788;3ips.A.413/23.789;3ips.B.413/23.589;3ipu.A.413/23.97;3ipu.B.413/23.735;5avi.A.413/23.846;5avi.C.413/23.846;5avl.A.413/23.867;1uhl.B.413/23.395	3ipq.A.434/27.405;3ips.A.434/27.149;3ips.B.434/27.236;3ipu.A.434/27.047;3ipu.B.434/26.78;5avi.A.434/27.216;5avi.C.434/27.163;5avl.A.434/27.092;1uhl.B.434/24.819	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
286	Q	none	none	none	none	-	4	0.018000000000000002	alpha-helix	Helices	core	Neutral & Polar	-	-	-	-	3ipq.A.413/23.116;3ips.A.413/23.214;3ips.B.413/23.185;3ipu.A.413/23.364;3ipu.B.413/23.213;5avi.A.413/23.37;5avi.C.413/23.212;5avl.A.413/23.218;1uhl.B.413/22.856	3ipq.A.434/25.849;3ips.A.434/25.841;3ips.B.434/25.986;3ipu.A.434/25.669;3ipu.B.434/25.505;5avi.A.434/25.93;5avi.C.434/25.822;5avl.A.434/25.76;1uhl.B.434/23.915	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
287	I	I>V	I>V (exome, AC = 1, AN = 251290, AF = 3.97947e-06)	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/22.731;3ips.A.413/22.898;3ips.B.413/22.801;3ipu.A.413/23.019;3ipu.B.413/22.771;5avi.A.413/22.967;5avi.C.413/22.895;5avl.A.413/22.868;1uhl.B.413/22.741	3ipq.A.434/22.454;3ips.A.434/22.339;3ips.B.434/22.438;3ipu.A.434/22.151;3ipu.B.434/21.976;5avi.A.434/22.385;5avi.C.434/22.279;5avl.A.434/22.248;1uhl.B.434/20.522	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
288	A	none	none	none	none	-	1	0.008	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/20.607;3ips.A.413/20.707;3ips.B.413/20.69;3ipu.A.413/20.807;3ipu.B.413/20.683;5avi.A.413/20.652;5avi.C.413/20.659;5avl.A.413/20.536;1uhl.B.413/20.251	3ipq.A.434/23.177;3ips.A.434/22.951;3ips.B.434/22.977;3ipu.A.434/22.661;3ipu.B.434/22.638;5avi.A.434/22.954;5avi.C.434/22.93;5avl.A.434/22.765;1uhl.B.434/20.628	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
289	L	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/18.069;3ips.A.413/18.306;3ips.B.413/18.068;3ipu.A.413/18.301;3ipu.B.413/18.157;5avi.A.413/18.187;5avi.C.413/18.193;5avl.A.413/18.205;1uhl.B.413/17.949	3ipq.A.434/24.122;3ips.A.434/23.939;3ips.B.434/23.926;3ipu.A.434/23.742;3ipu.B.434/23.652;5avi.A.434/24.082;5avi.C.434/24.031;5avl.A.434/23.798;1uhl.B.434/21.827	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
290	L	none	none	none	none	-	4	0.02	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/18.291;3ips.A.413/18.554;3ips.B.413/18.378;3ipu.A.413/18.49;3ipu.B.413/18.371;5avi.A.413/18.536;5avi.C.413/18.421;5avl.A.413/18.42;1uhl.B.413/18.488	3ipq.A.434/21.319;3ips.A.434/21.355;3ips.B.434/21.39;3ipu.A.434/21.042;3ipu.B.434/21.048;5avi.A.434/21.385;5avi.C.434/21.356;5avl.A.434/21.155;1uhl.B.434/19.495	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
291	K	none	none	none	none	-	46	0.195	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/18.2;3ips.A.413/18.485;3ips.B.413/18.41;3ipu.A.413/18.537;3ipu.B.413/18.194;5avi.A.413/18.32;5avi.C.413/18.267;5avl.A.413/18.441;1uhl.B.413/18.058	3ipq.A.434/18.513;3ips.A.434/18.31;3ips.B.434/18.507;3ipu.A.434/18.018;3ipu.B.434/18.024;5avi.A.434/18.428;5avi.C.434/18.278;5avl.A.434/18.281;1uhl.B.434/16.414	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
292	T	none	none	none	none	-	35	0.203	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/14.664;3ips.A.413/15.002;3ips.B.413/14.882;3ipu.A.413/15.002;3ipu.B.413/14.673;5avi.A.413/14.749;5avi.C.413/14.724;5avl.A.413/14.826;1uhl.B.413/14.539	3ipq.A.434/19.689;3ips.A.434/19.402;3ips.B.434/19.566;3ipu.A.434/19.277;3ipu.B.434/19.145;5avi.A.434/19.527;5avi.C.434/19.429;5avl.A.434/19.334;1uhl.B.434/17.219	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
293	S	none	none	none	none	-	0	0	alpha-helix	Helices	core	Neutral & Polar	-	-	-	-	3ipq.A.413/13.163;3ips.A.413/13.331;3ips.B.413/13.124;3ipu.A.413/13.385;3ipu.B.413/13.145;5avi.A.413/13.294;5avi.C.413/13.212;5avl.A.413/13.393;1uhl.B.413/13.125	3ipq.A.434/21.483;3ips.A.434/21.304;3ips.B.434/21.402;3ipu.A.434/21.115;3ipu.B.434/21.093;5avi.A.434/21.379;5avi.C.434/21.316;5avl.A.434/21.183;1uhl.B.434/19.512	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
294	A	A>T; A>V	A>T (exome, AC = 3, AN = 251060, AF = 1.19493e-05); A>V (exome, AC = 4, AN = 250982, AF = 1.59374e-05)	none	none	-	3	0.023	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/14.831;3ips.A.413/14.952;3ips.B.413/15.004;3ipu.A.413/15.127;3ipu.B.413/14.983;5avi.A.413/15.162;5avi.C.413/15.034;5avl.A.413/15.176;1uhl.B.413/14.695	3ipq.A.434/18.726;3ips.A.434/18.774;3ips.B.434/18.715;3ipu.A.434/18.542;3ipu.B.434/18.588;5avi.A.434/18.781;5avi.C.434/18.797;5avl.A.434/18.616;1uhl.B.434/16.886	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
295	I	none	none	none	none	-	13	0.066	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/12.341;3ips.A.413/12.648;3ips.B.413/12.555;3ipu.A.413/12.748;3ipu.B.413/12.632;5avi.A.413/12.739;5avi.C.413/12.63;5avl.A.413/12.772;1uhl.B.413/12.223	3ipq.A.434/17.538;3ips.A.434/17.461;3ips.B.434/17.597;3ipu.A.434/17.27;3ipu.B.434/17.277;5avi.A.434/17.593;5avi.C.434/17.604;5avl.A.434/17.302;1uhl.B.434/16.129	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
296	E	E>K	E>K (exome, AC = 1, AN = 250892, AF = 3.98578e-06)	none	none	-	2	0.009000000000000001	alpha-helix	Helices	core	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/9.465;3ips.A.413/9.766;3ips.B.413/9.6;3ipu.A.413/9.902;3ipu.B.413/9.658;5avi.A.413/9.886;5avi.C.413/9.782;5avl.A.413/9.899;1uhl.B.413/9.516	3ipq.A.434/21.278;3ips.A.434/21.186;3ips.B.434/21.327;3ipu.A.434/20.97;3ipu.B.434/20.956;5avi.A.434/21.309;5avi.C.434/21.337;5avl.A.434/20.988;1uhl.B.434/19.739	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
297	V	none	none	none	none	-	2	0.011000000000000001	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/12.282;3ips.A.413/12.56;3ips.B.413/12.488;3ipu.A.413/12.658;3ipu.B.413/12.47;5avi.A.413/12.676;5avi.C.413/12.593;5avl.A.413/12.728;1uhl.B.413/12.442	3ipq.A.434/22.243;3ips.A.434/22.179;3ips.B.434/22.245;3ipu.A.434/22.077;3ipu.B.434/22.034;5avi.A.434/22.446;5avi.C.434/22.449;5avl.A.434/22.103;1uhl.B.434/20.779	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
298	M	none	none	none	none	-	18	0.08	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/12.492;3ips.A.306/12.702;3ips.B.306/12.612;3ipu.A.306/12.686;3ipu.B.306/12.717;5avi.A.306/12.594;5avi.C.306/12.416;5avl.A.306/12.704;1uhl.B.306/12.514	3ipq.A.434/19.463;3ips.A.328/19.379;3ips.B.328/19.069;3ipu.A.328/19.235;3ipu.B.328/19.22;5avi.A.328/19.235;5avi.C.328/19.216;5avl.A.328/19.092;1uhl.B.434/18.481	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
299	L	none	none	none	none	-	6	0.03	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/10.354;3ips.A.413/10.722;3ips.B.413/10.593;3ipu.A.413/10.692;3ipu.B.413/10.523;5avi.A.306/10.603;5avi.C.413/10.552;5avl.A.413/10.695;1uhl.B.306/10.702	3ipq.A.328/19.777;3ips.A.328/18.927;3ips.B.328/18.621;3ipu.A.328/18.495;3ipu.B.328/18.655;5avi.A.328/18.601;5avi.C.328/18.727;5avl.A.328/18.57;1uhl.B.328/19.035	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
300	L	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/10.187;3ips.A.306/10.146;3ips.B.306/10.272;3ipu.A.306/10.182;3ipu.B.306/10.195;5avi.A.306/10.114;5avi.C.306/10.104;5avl.A.306/10.18;1uhl.B.306/10.264	3ipq.A.328/22.889;3ips.A.328/22.053;3ips.B.328/21.81;3ipu.A.328/21.653;3ipu.B.328/21.803;5avi.A.328/21.791;5avi.C.328/21.912;5avl.A.328/21.657;1uhl.B.328/22.132	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
301	E	none	none	none	none	-	22	0.099	alpha-helix	Helices	buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.306/9.089;3ips.A.306/9.113;3ips.B.306/9.087;3ipu.A.306/9.079;3ipu.B.306/9.104;5avi.A.306/9.05;5avi.C.306/8.871;5avl.A.306/9.043;1uhl.B.306/8.632	3ipq.A.328/21.898;3ips.A.328/21.069;3ips.B.328/20.709;3ipu.A.328/20.637;3ipu.B.328/20.564;5avi.A.328/20.735;5avi.C.328/20.658;5avl.A.328/20.464;1uhl.B.328/21.168	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
302	T	none	none	none	none	-	19	0.11	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.306/6.483;3ips.A.306/6.676;3ips.B.306/6.655;3ipu.A.306/6.712;3ipu.B.306/6.692;5avi.A.306/6.594;5avi.C.306/6.44;5avl.A.306/6.678;1uhl.B.306/6.5	3ipq.A.328/18.442;3ips.A.328/17.712;3ips.B.328/17.35;3ipu.A.328/17.296;3ipu.B.328/17.284;5avi.A.328/17.369;5avi.C.328/17.343;5avl.A.328/17.221;1uhl.B.328/17.706	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
303	S	none	none	none	none	-	3	0.019	alpha-helix	Helices	core	Neutral & Polar	-	-	-	-	3ipq.A.306/5.248;3ips.A.306/5.042;3ips.B.306/5.354;3ipu.A.306/5.19;3ipu.B.306/5.16;5avi.A.306/5.158;5avi.C.306/5.097;5avl.A.306/5.234;1uhl.B.306/5.671	3ipq.A.328/20.374;3ips.A.328/19.852;3ips.B.328/19.603;3ipu.A.328/19.503;3ipu.B.328/19.574;5avi.A.328/19.619;5avi.C.328/19.776;5avl.A.328/19.497;1uhl.B.328/20.019	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
304	R	R>W; R>Q	R>W (exome, AC = 1, AN = 251478, AF = 3.97649e-06); R>Q (exome, AC = 5, AN = 251472, AF = 1.98829e-05); R>Q (genome, AC = 2, AN = 31396, AF = 6.37024e-05)	none	none	-	60	0.21899999999999997	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.306/5.595;3ips.A.306/5.605;3ips.B.306/5.509;3ipu.A.306/5.707;3ipu.B.306/5.683;5avi.A.306/5.638;5avi.C.306/5.609;5avl.A.306/5.669;1uhl.B.306/5.351	3ipq.A.328/22.656;3ips.A.328/22.189;3ips.B.328/21.907;3ipu.A.328/21.828;3ipu.B.328/21.796;5avi.A.328/21.898;5avi.C.328/21.946;5avl.A.328/21.764;1uhl.B.328/22.147	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
305	R	R>M	R>M (genome, AC = 1, AN = 31404, AF = 3.18431e-05)	none	none	-	80	0.292	turn	coils	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.306/3.797;3ips.A.306/3.802;3ips.B.306/3.853;3ipu.A.306/3.815;3ipu.B.306/3.822;5avi.A.306/3.832;5avi.C.306/3.829;5avl.A.306/3.813;1uhl.B.306/3.872	3ipq.A.328/20.012;3ips.A.328/19.565;3ips.B.328/19.34;3ipu.A.328/19.339;3ipu.B.328/19.278;5avi.A.328/19.377;5avi.C.328/19.368;5avl.A.328/19.453;1uhl.B.328/19.896	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
306	Y	none	none	none	none	-	13	0.049	beta-sheet	beta-strand/sheet	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.306/0.0;3ips.A.306/0.0;3ips.B.306/0.0;3ipu.A.306/0.0;3ipu.B.306/0.0;5avi.A.306/0.0;5avi.C.306/0.0;5avl.A.306/0.0;1uhl.B.306/0.0	3ipq.A.328/18.778;3ips.A.328/18.736;3ips.B.328/18.472;3ipu.A.328/18.41;3ipu.B.328/18.473;5avi.A.328/18.378;5avi.C.328/18.493;5avl.A.328/18.395;1uhl.B.328/18.519	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
307	N	N>S	N>S (exome, AC = 5, AN = 251454, AF = 1.98844e-05)	none	none	-	49	0.251	beta-sheet	beta-strand/sheet	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.306/3.818;3ips.A.306/3.796;3ips.B.306/3.83;3ipu.A.306/3.81;3ipu.B.306/3.817;5avi.A.306/3.818;5avi.C.306/3.803;5avl.A.306/3.854;1uhl.B.306/3.81	3ipq.A.328/19.678;3ips.A.328/19.61;3ips.B.328/19.441;3ipu.A.328/19.177;3ipu.B.328/19.22;5avi.A.328/19.318;5avi.C.328/19.272;5avl.A.328/19.405;1uhl.B.328/19.271	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
308	P	none	none	none	none	-	74	0.465	turn	coils	Medium-buried	Special	-	-	-	-	3ipq.A.310/5.626;3ips.A.310/5.783;3ips.B.310/5.674;3ipu.A.310/5.677;3ipu.B.310/5.657;5avi.A.310/5.764;5avi.C.310/5.943;5avl.A.310/5.719;1uhl.B.310/5.593	3ipq.A.328/20.868;3ips.A.328/21.167;3ips.B.328/20.801;3ipu.A.328/20.772;3ipu.B.328/20.84;5avi.A.328/20.813;5avi.C.328/21.022;5avl.A.328/20.686;1uhl.B.328/20.524	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
309	G	G>A	G>A (exome, AC = 1, AN = 251438, AF = 3.97712e-06)	none	none	-	79	0.693	turn	coils	Medium-exposed	Special	-	-	-	-	3ipq.A.310/3.82;3ips.A.310/3.799;3ips.B.310/3.79;3ipu.A.310/3.822;3ipu.B.310/3.799;5avi.A.310/3.805;5avi.C.310/3.799;5avl.A.310/3.788;1uhl.B.310/3.735	3ipq.A.328/21.596;3ips.A.328/21.593;3ips.B.328/21.322;3ipu.A.328/21.071;3ipu.B.328/21.136;5avi.A.328/21.139;5avi.C.328/21.22;5avl.A.328/20.91;1uhl.B.328/20.49	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
310	S	none	none	none	none	-	79	0.51	turn	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ipq.A.310/0.0;3ips.A.310/0.0;3ips.B.310/0.0;3ipu.A.310/0.0;3ipu.B.310/0.0;5avi.A.310/0.0;5avi.C.310/0.0;5avl.A.310/0.0;1uhl.B.310/0.0	3ipq.A.328/18.152;3ips.A.328/18.119;3ips.B.328/17.796;3ipu.A.328/17.422;3ipu.B.328/17.521;5avi.A.328/17.593;5avi.C.328/17.793;5avl.A.328/17.312;1uhl.B.328/17.08	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
311	E	E>K; E>G	E>K (exome, AC = 1, AN = 251420, AF = 3.97741e-06); E>G (exome, AC = 1, AN = 251422, AF = 3.97738e-06)	none	none	-	86	0.386	turn	coils	Medium-buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.310/3.813;3ips.A.310/3.822;3ips.B.310/3.811;3ipu.A.312/3.781;3ipu.B.312/3.785;5avi.A.312/3.799;5avi.C.312/3.814;5avl.A.312/3.79;1uhl.B.310/3.823	3ipq.A.328/16.446;3ips.A.328/16.629;3ips.B.328/16.392;3ipu.A.328/16.178;3ipu.B.328/16.206;5avi.A.328/16.063;5avi.C.328/16.009;5avl.A.328/15.919;1uhl.B.328/15.888	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
312	S	S>R; S>T	S>R (exome, AC = 7, AN = 251418, AF = 2.78421e-05); S>T (exome, AC = 1, AN = 251392, AF = 3.97785e-06); S>R (genome, AC = 1, AN = 31402, AF = 3.18451e-05)	none	none	-	4	0.026000000000000002	beta-sheet	beta-strand/sheet	core	Neutral & Polar	-	-	-	-	3ipq.A.312/0.0;3ips.A.312/0.0;3ips.B.312/0.0;3ipu.A.312/0.0;3ipu.B.312/0.0;5avi.A.312/0.0;5avi.C.312/0.0;5avl.A.312/0.0;1uhl.B.312/0.0	3ipq.A.328/14.585;3ips.A.328/14.512;3ips.B.328/14.143;3ipu.A.328/14.026;3ipu.B.328/14.08;5avi.A.328/13.976;5avi.C.328/13.986;5avl.A.328/13.834;1uhl.B.328/14.048	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
313	I	none	none	none	none	-	0	0	beta-sheet	beta-strand/sheet	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/3.808;3ips.A.314/3.782;3ips.B.314/3.817;3ipu.A.312/3.792;3ipu.B.314/3.8;5avi.A.312/3.805;5avi.C.312/3.823;5avl.A.312/3.766;1uhl.B.314/3.891	3ipq.A.328/15.075;3ips.A.328/14.766;3ips.B.328/14.616;3ipu.A.328/14.33;3ipu.B.328/14.421;5avi.A.328/14.511;5avi.C.328/14.324;5avl.A.328/14.262;1uhl.B.328/14.728	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
314	T	none	none	none	none	-	33	0.192	beta-sheet	beta-strand/sheet	buried	Neutral & Polar	-	-	-	-	3ipq.A.314/0.0;3ips.A.314/0.0;3ips.B.314/0.0;3ipu.A.314/0.0;3ipu.B.314/0.0;5avi.A.314/0.0;5avi.C.314/0.0;5avl.A.314/0.0;1uhl.B.314/0.0	3ipq.A.328/16.623;3ips.A.328/16.097;3ips.B.328/16.244;3ipu.A.328/15.91;3ipu.B.328/15.996;5avi.A.328/15.876;5avi.C.328/15.806;5avl.A.328/16.071;1uhl.B.328/16.209	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
315	F	F>L	F>L (exome, AC = 2, AN = 251356, AF = 7.95684e-06)	none	none	-	33.5	0.14	beta-sheet	beta-strand/sheet	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.314/3.828;3ips.A.314/3.863;3ips.B.314/3.807;3ipu.A.314/3.791;3ipu.B.314/3.767;5avi.A.314/3.826;5avi.C.314/3.829;5avl.A.314/3.829	3ipq.A.328/16.899;3ips.A.328/15.875;3ips.B.328/15.781;3ipu.A.328/15.517;3ipu.B.328/15.388;5avi.A.328/15.466;5avi.C.328/15.496;5avl.A.328/15.863	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
316	L	none	none	none	none	-	74.5	0.371	turn	coils	Medium-buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/6.786;3ips.A.314/6.771;3ips.B.314/6.718;3ipu.A.314/5.989;3ipu.B.314/5.999;5avi.A.314/6.666;5avi.C.314/6.615;5avl.A.314/6.506	3ipq.A.328/19.914;3ips.A.328/18.277;3ips.B.328/17.99;3ipu.A.328/16.758;3ipu.B.328/16.873;5avi.A.328/17.974;5avi.C.328/18.229;5avl.A.328/18.512	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
317	K	none	none	none	none	-	184.5	0.782	turn	coils	exposed	Positively Charged & Polar	-	-	-	-	3ipq.A.314/5.945;3ips.A.314/5.995;3ips.B.314/5.864;3ipu.A.314/6.471;3ipu.B.314/6.402;5avi.A.314/6.238;5avi.C.314/6.207;5avl.A.314/6.304	3ipq.A.328/21.076;3ips.A.328/19.827;3ips.B.328/20.268;3ipu.A.328/19.516;3ipu.B.328/19.606;5avi.A.328/20.123;5avi.C.328/20.156;5avl.A.328/20.161	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
318	D	D>E	D>E (exome, AC = 1, AN = 251288, AF = 3.9795e-06)	none	none	-	135	0.6990000000000001	turn	coils	Medium-exposed	Negatively Charged & Polar	-	-	-	-	3ipq.A.314/6.559;3ips.A.314/6.809;3ips.B.314/6.282;3ipu.A.314/7.781;3ipu.B.314/7.74;5avi.A.314/6.563;5avi.C.314/6.583;5avl.A.314/6.88;1uhl.B.314/6.595	3ipq.A.328/19.033;3ips.A.328/18.12;3ips.B.328/18.722;3ipu.A.328/18.808;3ipu.B.328/18.77;5avi.A.328/18.434;5avi.C.328/18.481;5avl.A.328/18.09;1uhl.B.328/19.014	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
319	F	none	none	none	none	-	87	0.36200000000000004	beta-sheet	beta-strand/sheet	Medium-buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.314/5.336;3ips.A.314/6.17;3ips.B.314/5.658;3ipu.A.314/5.957;3ipu.B.314/5.728;5avi.A.314/5.522;5avi.C.314/5.595;5avl.A.314/5.831;1uhl.B.314/5.805	3ipq.A.328/15.29;3ips.A.328/14.573;3ips.B.328/15.123;3ipu.A.328/15.071;3ipu.B.328/15.084;5avi.A.328/14.699;5avi.C.328/14.77;5avl.A.328/14.259;1uhl.B.328/15.311	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
320	S	S>T	S>T (exome, AC = 2, AN = 251262, AF = 7.95982e-06); S>T (genome, AC = 1, AN = 31406, AF = 3.1841e-05)	none	none	-	58	0.374	beta-sheet	beta-strand/sheet	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.314/4.099;3ips.A.314/4.045;3ips.B.314/4.246;3ipu.A.314/4.196;3ipu.B.314/4.11;5avi.A.314/4.049;5avi.C.314/4.411;5avl.A.314/4.088;1uhl.B.314/4.196	3ipq.A.328/14.125;3ips.A.328/13.577;3ips.B.328/13.734;3ipu.A.328/13.585;3ipu.B.328/13.706;5avi.A.328/13.516;5avi.C.328/13.473;5avl.A.328/13.265;1uhl.B.328/13.247	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
321	Y	Y>N	Y>N (exome, AC = 1, AN = 251256, AF = 3.98e-06)	none	none	-	5	0.019	beta-sheet	beta-strand/sheet	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.312/5.159;3ips.A.312/5.241;3ips.B.312/5.151;3ipu.A.312/5.034;3ipu.B.312/5.024;5avi.A.312/5.059;5avi.C.312/5.036;5avl.A.312/5.039;1uhl.B.312/5.276	3ipq.A.328/10.819;3ips.A.328/10.377;3ips.B.328/10.366;3ipu.A.328/10.279;3ipu.B.328/10.32;5avi.A.328/10.184;5avi.C.328/10.212;5avl.A.328/10.105;1uhl.B.328/10.224	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
322	N	none	none	none	none	-	65	0.33299999999999996	loop	coils	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.312/4.494;3ips.A.312/4.631;3ips.B.312/4.28;3ipu.A.312/4.208;3ipu.B.312/4.283;5avi.A.312/4.254;5avi.C.312/4.196;5avl.A.312/4.12;1uhl.B.312/4.978	3ipq.A.328/10.265;3ips.A.328/10.105;3ips.B.328/10.033;3ipu.A.328/10.097;3ipu.B.328/10.034;5avi.A.328/9.975;5avi.C.328/10.052;5avl.A.328/9.886;1uhl.B.328/9.239	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
323	R	R>W	R>W (exome, AC = 4, AN = 251142, AF = 1.59272e-05)	none	none	-	78	0.285	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.312/7.508;3ips.A.312/7.691;3ips.B.312/7.244;3ipu.A.312/7.134;3ipu.B.312/7.347;5avi.A.312/7.274;5avi.C.312/7.227;5avl.A.312/7.101;1uhl.B.312/7.517	3ipq.A.328/8.784;3ips.A.328/9.044;3ips.B.328/8.912;3ipu.A.328/8.862;3ipu.B.328/8.81;5avi.A.328/8.791;5avi.C.328/8.847;5avl.A.328/8.805;1uhl.B.328/8.134	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
324	E	E>K	E>K (exome, AC = 1, AN = 251126, AF = 3.98206e-06)	none	none	-	124	0.556	alpha-helix	Helices	Medium-exposed	NegativelyCharged & Polar	-	-	-	-	3ipq.A.312/9.977;3ips.A.312/10.171;3ips.B.312/9.604;3ipu.A.312/9.685;3ipu.B.312/9.693;5avi.A.312/9.81;5avi.C.312/9.766;5avl.A.312/9.363;1uhl.B.312/10.107	3ipq.A.328/6.154;3ips.A.328/6.049;3ips.B.328/6.372;3ipu.A.328/6.222;3ipu.B.328/6.334;5avi.A.328/6.13;5avi.C.328/6.156;5avl.A.328/6.35;1uhl.B.328/5.681	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
325	D	none	none	none	none	-	27	0.14	alpha-helix	Helices	buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.312/9.609;3ips.A.312/9.493;3ips.B.312/9.276;3ipu.A.312/9.237;3ipu.B.312/9.299;5avi.A.312/9.092;5avi.C.312/9.056;5avl.A.312/8.859;1uhl.B.312/9.506	3ipq.A.328/5.15;3ips.A.328/5.166;3ips.B.328/5.029;3ipu.A.328/4.945;3ipu.B.328/4.946;5avi.A.328/5.001;5avi.C.328/5.058;5avl.A.328/5.131;1uhl.B.328/4.692	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
326	F	none	none	none	none	-	6	0.025	alpha-helix	Helices	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.312/10.567;3ips.A.312/10.135;3ips.B.312/9.807;3ipu.A.312/9.92;3ipu.B.312/9.874;5avi.A.312/9.837;5avi.C.312/9.771;5avl.A.312/9.627;1uhl.B.312/10.181	3ipq.A.328/5.333;3ips.A.328/5.636;3ips.B.328/5.571;3ipu.A.328/5.369;3ipu.B.328/5.396;5avi.A.328/5.475;5avi.C.328/5.516;5avl.A.328/5.44;1uhl.B.328/5.332	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
327	A	none	none	none	none	-	44	0.341	alpha-helix	Helices	Medium-buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.312/13.286;3ips.A.312/13.152;3ips.B.312/12.806;3ipu.A.312/12.838;3ipu.B.312/12.865;5avi.A.312/12.797;5avi.C.312/12.702;5avl.A.312/12.499;1uhl.B.312/12.8	3ipq.A.328/3.822;3ips.A.328/3.847;3ips.B.328/3.841;3ipu.A.328/3.797;3ipu.B.328/3.856;5avi.A.328/3.822;5avi.C.328/3.819;5avl.A.328/3.839;1uhl.B.328/3.823	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
328	K	K>E	K>E (exome, AC = 1, AN = 250954, AF = 3.98479e-06)	none	none	-	89	0.377	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.312/14.585;3ips.A.246/10.899;3ips.B.246/11.096;3ipu.A.246/11.1;3ipu.B.246/11.348;5avi.A.246/11.289;5avi.C.246/11.217;5avl.A.312/13.834;1uhl.B.312/14.048	3ipq.A.328/0.0;3ips.A.328/0.0;3ips.B.328/0.0;3ipu.A.328/0.0;3ipu.B.328/0.0;5avi.A.328/0.0;5avi.C.328/0.0;5avl.A.328/0.0;1uhl.B.328/0.0	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
329	A	none	none	none	none	-	0	0	turn	coils	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.312/15.278;3ips.A.246/12.498;3ips.B.246/12.484;3ipu.A.246/12.599;3ipu.B.246/12.741;5avi.A.246/12.803;5avi.C.246/13.017;5avl.A.312/13.745;1uhl.B.312/15.467	3ipq.A.328/3.799;3ips.A.328/3.833;3ips.B.328/3.833;3ipu.A.328/3.822;3ipu.B.328/3.833;5avi.A.328/3.827;5avi.C.328/3.828;5avl.A.328/3.823;1uhl.B.328/3.741	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
330	G	none	none	none	none	-	18	0.158	turn	coils	buried	Special	-	-	-	-	3ipq.A.312/17.522;3ips.A.246/13.209;3ips.B.246/12.99;3ipu.A.246/13.09;3ipu.B.246/13.311;5avi.A.246/13.255;5avi.C.246/13.318;5avl.A.312/16.375;1uhl.B.312/17.903	3ipq.A.328/5.301;3ips.A.328/5.319;3ips.B.328/5.453;3ipu.A.328/5.337;3ipu.B.328/5.285;5avi.A.328/5.44;5avi.C.328/5.345;5avl.A.328/5.332;1uhl.B.328/6.082	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
331	L	none	none	none	none	-	31	0.154	loop	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.312/15.904;3ips.A.312/15.351;3ips.B.312/15.361;3ipu.A.312/15.018;3ipu.B.312/15.155;5avi.A.312/15.299;5avi.C.312/15.218;5avl.A.312/15.032;1uhl.B.312/15.788	3ipq.A.328/7.336;3ips.A.328/7.328;3ips.B.328/7.264;3ipu.A.328/7.205;3ipu.B.328/7.343;5avi.A.328/7.321;5avi.C.328/7.377;5avl.A.328/7.278;1uhl.B.328/7.191	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
332	Q	none	none	none	none	-	52	0.231	loop	coils	buried	Neutral & Polar	-	-	-	-	3ipq.A.312/17.229;3ips.A.312/17.027;3ips.B.312/16.357;3ipu.A.312/16.426;3ipu.B.312/16.367;5avi.A.312/16.806;5avi.C.312/16.769;5avl.A.312/16.259;1uhl.B.312/16.015	3ipq.A.328/9.572;3ips.A.328/9.362;3ips.B.328/9.112;3ipu.A.328/9.143;3ipu.B.328/9.209;5avi.A.328/9.484;5avi.C.328/9.671;5avl.A.328/9.077;1uhl.B.328/6.664	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
333	V	V>M	V>M (exome, AC = 1, AN = 251428, AF = 3.97728e-06)	none	none	-	83	0.47700000000000004	alpha-helix	Helices	Medium-buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.312/15.736;3ips.A.312/15.264;3ips.B.312/14.828;3ipu.A.312/14.792;3ipu.B.312/14.892;5avi.A.312/15.255;5avi.C.312/15.448;5avl.A.312/14.961;1uhl.B.312/16.813	3ipq.A.328/10.543;3ips.A.328/10.466;3ips.B.328/10.526;3ipu.A.328/10.422;3ipu.B.328/10.644;5avi.A.328/10.769;5avi.C.328/11.005;5avl.A.328/10.515;1uhl.B.328/10.223	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
334	E	none	none	none	none	-	117	0.525	alpha-helix	Helices	Medium-exposed	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/15.094;3ips.A.413/14.999;3ips.B.413/14.833;3ipu.A.413/15.132;3ipu.B.413/15.011;5avi.A.413/15.177;5avi.C.413/15.181;5avl.A.413/15.135;1uhl.B.312/15.592	3ipq.A.328/13.954;3ips.A.328/13.938;3ips.B.328/13.923;3ipu.A.328/13.816;3ipu.B.328/14.003;5avi.A.328/14.179;5avi.C.328/14.24;5avl.A.328/13.867;1uhl.B.328/12.553	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
335	F	none	none	none	none	-	12	0.05	alpha-helix	Helices	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/13.682;3ips.A.413/13.043;3ips.B.413/12.815;3ipu.A.413/13.247;3ipu.B.413/13.13;5avi.A.413/13.4;5avi.C.413/13.457;5avl.A.413/13.205;1uhl.B.413/13.65	3ipq.A.328/13.035;3ips.A.328/13.309;3ips.B.328/13.286;3ipu.A.328/13.069;3ipu.B.328/13.2;5avi.A.328/13.251;5avi.C.328/13.157;5avl.A.328/13.1;1uhl.B.328/13.027	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
336	I	none	none	none	none	-	2	0.01	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.312/12.025;3ips.A.312/11.795;3ips.B.312/11.605;3ipu.A.312/11.453;3ipu.B.312/11.374;5avi.A.312/11.639;5avi.C.312/11.638;5avl.A.312/11.455;1uhl.B.312/11.756	3ipq.A.328/11.075;3ips.A.328/11.275;3ips.B.328/11.021;3ipu.A.328/10.891;3ipu.B.328/11.078;5avi.A.328/11.181;5avi.C.328/11.202;5avl.A.328/11.077;1uhl.B.328/10.81	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
337	N	N>H	N>H (exome, AC = 70, AN = 251458, AF = 0.000278377); N>H (genome, AC = 13, AN = 31394, AF = 0.000414092)	none	none	-	78	0.4	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.312/12.556;3ips.A.312/12.284;3ips.B.312/11.94;3ipu.A.312/11.777;3ipu.B.312/11.712;5avi.A.312/11.993;5avi.C.312/12.188;5avl.A.312/12.039;1uhl.B.312/11.923	3ipq.A.328/13.803;3ips.A.328/14.023;3ips.B.328/13.745;3ipu.A.328/13.667;3ipu.B.328/13.837;5avi.A.328/14.105;5avi.C.328/14.19;5avl.A.328/14.062;1uhl.B.328/13.597	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
338	P	none	none	none	none	-	42	0.264	alpha-helix	Helices	Medium-buried	Special	-	-	-	-	3ipq.A.413/9.782;3ips.A.413/9.496;3ips.B.413/9.523;3ipu.A.413/9.707;3ipu.B.413/9.75;5avi.A.413/9.791;5avi.C.413/9.685;5avl.A.413/9.58;1uhl.B.413/10.056	3ipq.A.328/16.864;3ips.A.328/16.792;3ips.B.328/16.568;3ipu.A.328/16.509;3ipu.B.328/16.53;5avi.A.328/16.657;5avi.C.328/16.818;5avl.A.328/16.657;1uhl.B.328/16.312	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
339	I	I>T	I>T (exome, AC = 1, AN = 251460, AF = 3.97678e-06)	none	none	-	6	0.03	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/10.296;3ips.A.306/10.197;3ips.B.413/10.241;3ipu.A.413/10.331;3ipu.B.306/10.304;5avi.A.306/10.429;5avi.C.306/10.352;5avl.A.413/10.234;1uhl.B.413/10.878	3ipq.A.328/15.798;3ips.A.328/15.367;3ips.B.328/15.23;3ipu.A.328/15.172;3ipu.B.328/15.192;5avi.A.328/15.199;5avi.C.328/15.329;5avl.A.328/15.201;1uhl.B.328/14.932	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
340	F	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.306/8.484;3ips.A.306/8.145;3ips.B.306/8.355;3ipu.A.312/8.095;3ipu.B.312/8.142;5avi.A.312/8.421;5avi.C.312/8.412;5avl.A.312/8.502;1uhl.B.312/8.159	3ipq.A.328/15.524;3ips.A.328/15.589;3ips.B.328/15.394;3ipu.A.328/15.269;3ipu.B.328/15.286;5avi.A.328/15.401;5avi.C.328/15.537;5avl.A.328/15.35;1uhl.B.328/14.883	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
341	E	E>K	E>K (exome, AC = 4, AN = 251460, AF = 1.59071e-05)	none	none	B:341:GLU-N/3.8-A:375:GLN;B:341:GLU-N/3.86-A:375:GLN;B:341:GLU-N/3.78-A:375:GLN;B:341:GLU-N/3.82-A:375:GLN;B:341:GLU-N/3.44-A:375:GLN;C:341:GLU-N/3.78-A:375:GLN;C:341:GLU-N/3.29-A:375:GLN;B:177:GLU-N/3.81-A:211:GLN;B:177:GLU-N/3.71-A:211:GLN;B:177:GLU-N/3.05-A:211:GLN	72	0.32299999999999995	alpha-helix	Helices	Medium-buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/10.561;3ips.A.306/10.425;3ips.B.413/10.371;3ipu.A.413/10.383;3ipu.B.413/10.482;5avi.A.413/10.516;5avi.C.413/10.469;5avl.A.413/10.292;1uhl.B.312/10.999	3ipq.A.328/18.729;3ips.A.328/18.726;3ips.B.328/18.56;3ipu.A.328/18.515;3ipu.B.328/18.623;5avi.A.328/18.796;5avi.C.328/18.88;5avl.A.328/18.712;1uhl.B.328/18.118	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
342	F	none	none	none	none	-	12	0.05	alpha-helix	Helices	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/7.772;3ips.A.413/7.787;3ips.B.413/7.599;3ipu.A.413/7.474;3ipu.B.413/7.642;5avi.A.413/7.734;5avi.C.413/7.652;5avl.A.413/7.519;1uhl.B.413/8.316	3ipq.A.328/20.477;3ips.A.328/20.313;3ips.B.328/20.163;3ipu.A.328/20.081;3ipu.B.328/20.128;5avi.A.328/20.268;5avi.C.328/20.4;5avl.A.328/20.193;1uhl.B.328/19.787	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
343	S	none	none	none	none	-	0	0	alpha-helix	Helices	core	Neutral & Polar	-	-	-	-	3ipq.A.306/6.296;3ips.A.306/6.23;3ips.B.306/6.34;3ipu.A.306/6.379;3ipu.B.306/6.146;5avi.A.306/6.263;5avi.C.306/6.279;5avl.A.306/6.416;1uhl.B.306/6.622	3ipq.A.328/19.613;3ips.A.328/19.617;3ips.B.328/19.283;3ipu.A.328/19.149;3ipu.B.328/19.151;5avi.A.328/19.222;5avi.C.328/19.406;5avl.A.328/19.227;1uhl.B.328/18.957	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
344	R	none	none	none	none	-	77	0.281	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.306/7.566;3ips.A.306/7.421;3ips.B.306/7.435;3ipu.A.306/7.462;3ipu.B.306/7.313;5avi.A.306/7.414;5avi.C.306/7.353;5avl.A.306/7.494;1uhl.B.306/7.707	3ipq.A.328/21.084;3ips.A.328/21.123;3ips.B.328/20.792;3ipu.A.328/20.708;3ipu.B.328/20.854;5avi.A.328/20.882;5avi.C.328/21.019;5avl.A.328/20.843;1uhl.B.328/20.598	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
345	A	A>V	A>V (exome, AC = 1, AN = 251462, AF = 3.97674e-06)	none	none	-	17	0.132	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/10.21;3ips.A.306/10.218;3ips.B.413/10.185;3ipu.A.413/10.076;3ipu.B.413/10.103;5avi.A.413/10.254;5avi.C.306/10.276;5avl.A.413/10.191;1uhl.B.413/10.574	3ipq.A.328/24.133;3ips.A.328/24.078;3ips.B.328/23.828;3ipu.A.328/23.825;3ipu.B.328/23.914;5avi.A.328/23.889;5avi.C.328/24.002;5avl.A.328/23.817;1uhl.B.328/23.604	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
346	M	M>V	M>V (exome, AC = 8, AN = 251474, AF = 3.18124e-05)	none	none	-	2	0.009000000000000001	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/9.051;3ips.A.306/8.967;3ips.B.306/9.008;3ipu.A.306/8.95;3ipu.B.306/8.746;5avi.A.306/8.908;5avi.C.306/8.843;5avl.A.306/9.01;1uhl.B.306/9.398	3ipq.A.328/24.706;3ips.A.328/24.515;3ips.B.328/24.347;3ipu.A.328/24.215;3ipu.B.328/24.107;5avi.A.328/24.314;5avi.C.328/24.418;5avl.A.328/24.15;1uhl.B.328/24.31	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
347	N	N>H	N>H (exome, AC = 1, AN = 251468, AF = 3.97665e-06)	none	none	-	40	0.205	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.306/7.384;3ips.A.306/7.065;3ips.B.306/7.178;3ipu.A.306/6.989;3ipu.B.306/6.918;5avi.A.306/7.184;5avi.C.306/7.086;5avl.A.306/7.105;1uhl.B.306/7.092	3ipq.A.328/24.666;3ips.A.328/24.498;3ips.B.328/24.326;3ipu.A.328/24.1;3ipu.B.328/24.196;5avi.A.328/24.29;5avi.C.328/24.337;5avl.A.328/24.143;1uhl.B.328/23.917	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
348	E	none	none	none	none	-	113	0.507	alpha-helix	Helices	Medium-exposed	NegativelyCharged & Polar	-	-	-	-	3ipq.A.306/10.995;3ips.A.306/10.498;3ips.B.306/10.705;3ipu.A.306/10.57;3ipu.B.306/10.439;5avi.A.306/10.809;5avi.C.306/10.692;5avl.A.306/10.642;1uhl.B.306/10.479	3ipq.A.328/27.459;3ips.A.328/27.239;3ips.B.328/27.213;3ipu.A.328/27.063;3ipu.B.328/27.133;5avi.A.328/27.242;5avi.C.328/27.237;5avl.A.328/27.06;1uhl.B.328/26.641	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
349	L	none	none	none	none	-	6	0.03	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/12.437;3ips.A.306/12.348;3ips.B.306/12.361;3ipu.A.306/12.123;3ipu.B.306/12.03;5avi.A.306/12.338;5avi.C.306/12.243;5avl.A.306/12.16;1uhl.B.306/12.473	3ipq.A.328/29.56;3ips.A.328/29.588;3ips.B.328/29.286;3ipu.A.328/29.056;3ipu.B.328/29.084;5avi.A.328/29.246;5avi.C.328/29.285;5avl.A.328/29.078;1uhl.B.328/29.014	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
350	Q	none	none	none	none	-	130	0.578	turn	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ipq.A.306/11.081;3ips.A.306/10.823;3ips.B.306/10.903;3ipu.A.306/10.728;3ipu.B.306/10.751;5avi.A.306/10.932;5avi.C.306/10.858;5avl.A.306/10.644;1uhl.B.306/11.347	3ipq.A.328/29.397;3ips.A.328/29.176;3ips.B.328/28.957;3ipu.A.328/28.761;3ipu.B.328/28.871;5avi.A.328/28.945;5avi.C.328/29.008;5avl.A.328/28.673;1uhl.B.328/29.213	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
351	L	L>V	L>V (exome, AC = 4, AN = 251458, AF = 1.59072e-05)	none	none	-	20	0.1	loop	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/12.045;3ips.A.306/11.925;3ips.B.306/12.217;3ipu.A.306/11.786;3ipu.B.306/11.888;5avi.A.306/11.824;5avi.C.306/11.639;5avl.A.306/11.656;1uhl.B.306/12.581	3ipq.A.328/30.104;3ips.A.328/29.816;3ips.B.328/29.763;3ipu.A.328/29.284;3ipu.B.328/29.421;5avi.A.328/29.394;5avi.C.328/29.388;5avl.A.328/29.202;1uhl.B.328/30.22	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
352	N	N>D; N>S	N>D (exome, AC = 1, AN = 251460, AF = 3.97678e-06); N>S (exome, AC = 2, AN = 251462, AF = 7.95349e-06)	none	none	-	47	0.24100000000000002	loop	coils	buried	Neutral & Polar	-	-	-	-	3ipq.A.306/13.254;3ips.A.306/13.047;3ips.B.306/13.475;3ipu.A.306/13.149;3ipu.B.306/13.188;5avi.A.306/13.118;5avi.C.306/13.537;5avl.A.306/12.99;1uhl.B.306/13.263	3ipq.A.328/31.451;3ips.A.328/30.919;3ips.B.328/31.002;3ipu.A.328/30.591;3ipu.B.328/30.608;5avi.A.328/30.607;5avi.C.328/31.108;5avl.A.328/30.438;1uhl.B.328/31.103	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
353	D	D>A	D>A (exome, AC = 1, AN = 251458, AF = 3.97681e-06)	none	none	-	73	0.37799999999999995	alpha-helix	Helices	Medium-buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.306/14.118;3ips.A.306/13.96;3ips.B.306/14.322;3ipu.A.306/14.141;3ipu.B.306/14.337;5avi.A.306/14.049;5avi.C.306/14.011;5avl.A.306/14.083;1uhl.B.306/14.231	3ipq.A.328/31.296;3ips.A.328/30.559;3ips.B.328/30.613;3ipu.A.328/30.277;3ipu.B.328/30.431;5avi.A.328/30.267;5avi.C.328/30.396;5avl.A.328/30.253;1uhl.B.328/31.105	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
354	A	A>V	A>V (exome, AC = 1, AN = 251454, AF = 3.97687e-06)	none	none	-	6	0.047	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/17.331;3ips.A.306/17.252;3ips.B.306/17.41;3ipu.A.306/17.224;3ipu.B.306/17.417;5avi.A.306/17.18;5avi.C.306/17.109;5avl.A.306/17.242;1uhl.B.306/17.29	3ipq.A.328/34.278;3ips.A.328/33.54;3ips.B.328/33.328;3ipu.A.328/33.148;3ipu.B.328/33.336;5avi.A.328/33.156;5avi.C.328/33.213;5avl.A.328/33.236;1uhl.B.328/33.818	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
355	E	E>K	E>K (exome, AC = 2, AN = 251452, AF = 7.9538e-06)	none	none	-	0	0	alpha-helix	Helices	core	NegativelyCharged & Polar	-	-	-	-	3ipq.A.306/15.992;3ips.A.306/15.893;3ips.B.306/16.12;3ipu.A.306/15.895;3ipu.B.306/16.008;5avi.A.306/15.914;5avi.C.306/15.769;5avl.A.306/15.76;1uhl.B.306/16.27	3ipq.A.328/32.875;3ips.A.328/32.254;3ips.B.328/32.135;3ipu.A.328/31.859;3ipu.B.328/31.997;5avi.A.328/32.016;5avi.C.328/32.013;5avl.A.328/31.815;1uhl.B.328/32.648	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
356	F	none	none	none	none	-	11	0.046	alpha-helix	Helices	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.306/13.483;3ips.A.306/13.375;3ips.B.306/13.579;3ipu.A.306/13.467;3ipu.B.306/13.551;5avi.A.306/13.415;5avi.C.306/13.229;5avl.A.306/13.413;1uhl.B.306/13.653	3ipq.A.328/29.486;3ips.A.328/28.736;3ips.B.328/28.63;3ipu.A.328/28.407;3ipu.B.328/28.539;5avi.A.328/28.551;5avi.C.328/28.523;5avl.A.328/28.445;1uhl.B.328/29.211	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
357	A	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/16.46;3ips.A.306/16.34;3ips.B.306/16.61;3ipu.A.306/16.55;3ipu.B.306/16.653;5avi.A.306/16.393;5avi.C.306/16.184;5avl.A.306/16.467;1uhl.B.306/16.289	3ipq.A.434/31.206;3ips.A.328/30.522;3ips.B.328/30.45;3ipu.A.328/30.286;3ipu.B.328/30.36;5avi.A.328/30.23;5avi.C.328/30.139;5avl.A.328/30.234;1uhl.B.434/29.846	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
358	L	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/16.54;3ips.A.413/16.572;3ips.B.413/16.68;3ipu.A.413/16.498;3ipu.B.413/16.518;5avi.A.413/16.565;5avi.C.413/16.504;5avl.A.413/16.508;1uhl.B.413/16.921	3ipq.A.434/33.092;3ips.A.328/32.761;3ips.B.328/32.784;3ipu.A.328/32.534;3ipu.B.328/32.736;5avi.A.328/32.641;5avi.C.328/32.602;5avl.A.328/32.483;1uhl.B.434/31.984	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
359	L	L>F	L>F (exome, AC = 1, AN = 251426, AF = 3.97731e-06)	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/12.79;3ips.A.413/12.778;3ips.B.413/12.873;3ipu.A.413/12.657;3ipu.B.413/12.718;5avi.A.413/12.749;5avi.C.413/12.67;5avl.A.413/12.724;1uhl.B.413/13.235	3ipq.A.434/30.886;3ips.A.328/30.289;3ips.B.328/30.162;3ipu.A.328/29.9;3ipu.B.328/30.137;5avi.A.328/30.073;5avi.C.328/30.067;5avl.A.328/29.847;1uhl.B.434/29.621	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
360	I	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/13.677;3ips.A.413/13.969;3ips.B.413/13.837;3ipu.A.413/13.74;3ipu.B.413/13.864;5avi.A.413/13.731;5avi.C.413/13.67;5avl.A.413/13.862;1uhl.B.413/13.746	3ipq.A.434/27.81;3ips.A.434/27.934;3ips.B.434/27.997;3ipu.A.434/27.608;3ipu.B.434/27.702;5avi.A.434/27.891;5avi.C.434/27.84;5avl.A.434/27.644;1uhl.B.434/26.454	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
361	A	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/16.19;3ips.A.413/16.384;3ips.B.413/16.395;3ipu.A.413/16.239;3ipu.B.413/16.326;5avi.A.413/16.117;5avi.C.413/16.091;5avl.A.413/16.292;1uhl.B.413/16.268	3ipq.A.434/29.954;3ips.A.434/30.024;3ips.B.434/30.113;3ipu.A.434/29.632;3ipu.B.434/29.733;5avi.A.434/29.967;5avi.C.434/29.921;5avl.A.434/29.781;1uhl.B.434/28.301	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
362	I	I>V	I>V (exome, AC = 1, AN = 251404, AF = 3.97766e-06); I>V (genome, AC = 1, AN = 31374, AF = 3.18735e-05)	none	none	C:362:ILE-N/3.87-A:409:MET;B:198:ILE-N/3.62-A:245:MET	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/13.967;3ips.A.413/14.118;3ips.B.413/14.041;3ipu.A.413/14.048;3ipu.B.413/14.089;5avi.A.413/13.849;5avi.C.413/13.86;5avl.A.413/14.056;1uhl.B.413/14.055	3ipq.A.434/30.965;3ips.A.434/30.888;3ips.B.434/30.992;3ipu.A.434/30.726;3ipu.B.434/30.651;5avi.A.434/30.917;5avi.C.434/30.908;5avl.A.434/30.721;1uhl.B.434/29.206	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
363	S	none	none	none	none	-	1	0.006	alpha-helix	Helices	core	Neutral & Polar	-	-	-	-	3ipq.A.413/11.607;3ips.A.413/11.79;3ips.B.413/11.728;3ipu.A.413/11.737;3ipu.B.413/11.784;5avi.A.413/11.68;5avi.C.413/11.619;5avl.A.413/11.764;1uhl.B.413/11.563	3ipq.A.434/27.401;3ips.A.434/27.325;3ips.B.434/27.444;3ipu.A.434/27.123;3ipu.B.434/27.043;5avi.A.434/27.255;5avi.C.434/27.274;5avl.A.434/27.125;1uhl.B.434/25.631	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
364	I	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/14.989;3ips.A.413/15.148;3ips.B.413/15.081;3ipu.A.413/15.134;3ipu.B.413/15.165;5avi.A.413/15.142;5avi.C.413/15.051;5avl.A.413/15.147;1uhl.B.413/14.89	3ipq.A.434/26.477;3ips.A.434/26.424;3ips.B.434/26.42;3ipu.A.434/26.181;3ipu.B.434/26.182;5avi.A.434/26.354;5avi.C.434/26.301;5avl.A.434/26.177;1uhl.B.434/24.55	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
365	F	F>L	F>L (exome, AC = 1, AN = 251370, AF = 3.9782e-06)	none	none	-	0	0	turn	coils	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/16.514;3ips.A.413/16.726;3ips.B.413/16.581;3ipu.A.413/16.683;3ipu.B.413/16.674;5avi.A.413/16.575;5avi.C.413/16.485;5avl.A.413/16.612;1uhl.B.413/16.473	3ipq.A.434/29.669;3ips.A.434/29.513;3ips.B.434/29.568;3ipu.A.434/29.338;3ipu.B.434/29.336;5avi.A.434/29.475;5avi.C.434/29.424;5avl.A.434/29.236;1uhl.B.434/27.464	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
366	S	none	none	none	none	-	4	0.026000000000000002	loop	coils	core	Neutral & Polar	-	-	-	-	3ipq.A.413/14.465;3ips.A.413/14.575;3ips.B.413/14.501;3ipu.A.413/14.62;3ipu.B.413/14.543;5avi.A.413/14.398;5avi.C.413/14.381;5avl.A.413/14.441;1uhl.B.413/14.235	3ipq.A.434/29.106;3ips.A.434/28.849;3ips.B.434/28.994;3ipu.A.434/28.682;3ipu.B.434/28.544;5avi.A.434/28.929;5avi.C.434/28.887;5avl.A.434/28.767;1uhl.B.434/26.655	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
367	A	none	none	none	none	-	13	0.10099999999999999	turn	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/17.351;3ips.A.413/17.417;3ips.B.413/17.34;3ipu.A.413/17.437;3ipu.B.413/17.359;5avi.A.413/17.094;5avi.C.413/17.087;5avl.A.413/17.279;1uhl.B.413/16.985	3ipq.A.434/30.845;3ips.A.434/30.574;3ips.B.434/30.803;3ipu.A.434/30.405;3ipu.B.434/30.292;5avi.A.434/30.643;5avi.C.434/30.544;5avl.A.434/30.377;1uhl.B.434/28.425	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
368	D	none	none	none	none	B:368:ASP-N/3.59-A:413:SER;B:368:ASP-N/3.38-A:413:SER;B:368:ASP-N/3.77-A:413:SER;B:368:ASP-N/2.78-A:413:SER;B:368:ASP-N/3.47-A:413:SER;B:368:ASP-N/3.48-A:413:SER;B:368:ASP-N/3.62-A:413:SER;B:368:ASP-N/2.89-A:413:SER;C:368:ASP-N/3.43-A:413:SER;C:368:ASP-N/3.43-A:413:SER;C:368:ASP-N/3.69-A:413:SER;C:368:ASP-N/3.27-A:413:SER;C:368:ASP-N/2.81-A:413:SER;B:204:ASP-N/3.64-A:249:SER;B:204:ASP-N/3.6-A:249:SER;B:204:ASP-N/3.59-A:249:SER;B:204:ASP-N/2.91-A:249:SER	56	0.29	turn	coils	Medium-buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.413/15.752;3ips.A.413/15.713;3ips.B.413/15.797;3ipu.A.413/15.742;3ipu.B.413/15.663;5avi.A.413/15.558;5avi.C.413/15.474;5avl.A.413/15.591;1uhl.B.413/15.345	3ipq.A.434/29.426;3ips.A.434/28.95;3ips.B.434/29.133;3ipu.A.434/28.756;3ipu.B.434/28.716;5avi.A.434/29.013;5avi.C.434/28.882;5avl.A.434/28.79;1uhl.B.434/26.431	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
369	R	R>Q; R>W	R>Q (exome, AC = 4, AN = 250908, AF = 1.59421e-05); R>W (genome, AC = 1, AN = 31376, AF = 3.18715e-05)	none	none	-	11	0.04	bend	coils	core	Positively Charged & Polar	-	-	-	-	3ipq.A.413/15.64;3ips.A.413/15.801;3ips.B.413/15.624;3ipu.A.413/15.746;3ipu.B.413/15.625;5avi.A.413/15.643;5avi.C.413/15.583;5avl.A.413/15.684;1uhl.B.413/15.517	3ipq.A.434/25.777;3ips.A.434/25.335;3ips.B.434/25.41;3ipu.A.434/25.103;3ipu.B.434/25.06;5avi.A.434/25.398;5avi.C.434/25.285;5avl.A.434/25.167;1uhl.B.434/22.792	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
370	P	none	none	none	none	-	79	0.49700000000000005	turn	coils	Medium-buried	Special	-	-	-	-	3ipq.A.413/18.287;3ips.A.413/18.451;3ips.B.413/18.277;3ipu.A.413/18.471;3ipu.B.413/18.297;5avi.A.413/18.452;5avi.C.413/18.405;5avl.A.413/18.396;1uhl.B.413/18.148	3ipq.A.434/24.753;3ips.A.434/24.194;3ips.B.434/24.314;3ipu.A.434/23.955;3ipu.B.434/23.936;5avi.A.434/24.176;5avi.C.434/24.097;5avl.A.434/24.112;1uhl.B.434/21.566	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
371	N	N>Y	N>Y (exome, AC = 1, AN = 251106, AF = 3.98238e-06)	none	none	-	115	0.59	turn	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ipq.A.413/21.784;3ips.A.413/21.911;3ips.B.413/21.751;3ipu.A.413/21.948;3ipu.B.413/21.825;5avi.A.413/22.019;5avi.C.413/21.958;5avl.A.413/21.958;1uhl.B.413/21.813	3ipq.A.434/25.915;3ips.A.434/25.562;3ips.B.434/25.646;3ipu.A.434/25.383;3ipu.B.434/25.31;5avi.A.434/25.505;5avi.C.434/25.415;5avl.A.434/25.588;1uhl.B.434/23.279	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
372	V	V>M	V>M (exome, AC = 1, AN = 251072, AF = 3.98292e-06)	none	none	-	15	0.086	loop	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/21.587;3ips.A.413/21.551;3ips.B.413/21.45;3ipu.A.413/21.675;3ipu.B.413/21.6;5avi.A.413/21.656;5avi.C.413/21.67;5avl.A.413/21.592;1uhl.B.413/22.133	3ipq.A.434/28.303;3ips.A.434/27.934;3ips.B.434/27.857;3ipu.A.434/27.839;3ipu.B.434/27.724;5avi.A.434/27.927;5avi.C.434/27.968;5avl.A.434/27.888;1uhl.B.434/25.698	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
373	Q	Q>R	Q>R (exome, AC = 1, AN = 251130, AF = 3.982e-06)	none	none	-	157	0.698	bend	coils	Medium-exposed	Neutral & Polar	-	-	-	-	3ipq.A.413/25.001;3ips.A.413/24.977;3ips.B.413/24.905;3ipu.A.413/25.151;3ipu.B.413/25.052;5avi.A.413/25.103;5avi.C.413/25.151;5avl.A.413/25.03;1uhl.B.413/25.509	3ipq.A.434/31.384;3ips.A.434/30.99;3ips.B.434/30.944;3ipu.A.434/30.864;3ipu.B.434/30.79;5avi.A.434/31.018;5avi.C.434/31.017;5avl.A.434/31.031;1uhl.B.434/29.054	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
374	D	none	none	none	none	-	73	0.37799999999999995	loop	coils	Medium-buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.413/25.079;3ips.A.413/25.24;3ips.B.413/25.219;3ipu.A.413/25.197;3ipu.B.413/25.082;5avi.A.413/25.147;5avi.C.413/25.149;5avl.A.413/24.979;1uhl.B.413/25.064	3ipq.A.434/33.808;3ips.A.434/33.641;3ips.B.434/33.658;3ipu.A.434/33.334;3ipu.B.434/33.145;5avi.A.434/33.544;5avi.C.434/33.496;5avl.A.434/33.476;1uhl.B.434/31.339	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
375	Q	Q>K	Q>K (exome, AC = 1, AN = 251150, AF = 3.98168e-06)	none	none	B:375:GLN-N/3.87-A:344:ARG;B:375:GLN-N/3.59-A:341:GLU;A:375:GLN-H/3.29-C:341:GLU;C:375:GLN-N/3.8-A:341:GLU;C:375:GLN-N/3.8-A:341:GLU;C:375:GLN-N/3.42-A:341:GLU;C:375:GLN-N/3.74-A:341:GLU;C:375:GLN-N/3.83-A:341:GLU;A:211:GLN-H/3.05-B:177:GLU	63	0.28	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/22.109;3ips.A.413/22.144;3ips.B.413/22.116;3ipu.A.413/22.193;3ipu.B.413/22.138;5avi.A.413/22.092;5avi.C.413/22.115;5avl.A.413/21.937;1uhl.B.413/21.996	3ipq.A.434/33.656;3ips.A.434/33.316;3ips.B.434/33.343;3ipu.A.434/33.183;3ipu.B.434/33.062;5avi.A.434/33.357;5avi.C.434/33.289;5avl.A.434/33.188;1uhl.B.434/31.02	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
376	L	none	none	none	none	-	94	0.46799999999999997	alpha-helix	Helices	Medium-buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/23.97;3ips.A.413/23.859;3ips.B.413/23.79;3ipu.A.413/24.057;3ipu.B.413/23.996;5avi.A.413/23.768;5avi.C.413/23.788;5avl.A.413/23.773;1uhl.B.413/23.529	3ipq.A.434/37.194;3ips.A.434/36.854;3ips.B.434/36.857;3ipu.A.434/36.766;3ipu.B.434/36.635;5avi.A.434/36.898;5avi.C.434/36.823;5avl.A.434/36.709;1uhl.B.434/34.428	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
377	Q	none	none	none	none	-	67	0.298	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/24.437;3ips.A.413/24.356;3ips.B.413/24.336;3ipu.A.413/24.49;3ipu.B.413/24.493;5avi.A.413/24.315;5avi.C.413/24.283;5avl.A.413/24.392;1uhl.B.413/24.086	3ipq.A.434/36.426;3ips.A.434/36.309;3ips.B.434/36.368;3ipu.A.434/36.121;3ipu.B.434/35.945;5avi.A.434/36.356;5avi.C.434/36.336;5avl.A.434/36.096;1uhl.B.434/33.604	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
378	V	none	none	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/20.862;3ips.A.413/20.926;3ips.B.413/20.956;3ipu.A.413/21.015;3ipu.B.413/20.989;5avi.A.413/20.817;5avi.C.413/20.794;5avl.A.413/20.907;1uhl.B.413/20.516	3ipq.A.434/33.207;3ips.A.434/33.015;3ips.B.434/33.141;3ipu.A.434/32.846;3ipu.B.434/32.748;5avi.A.434/33.074;5avi.C.434/33.048;5avl.A.434/32.891;1uhl.B.434/30.687	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
379	E	none	none	none	none	-	41	0.184	alpha-helix	Helices	buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/19.735;3ips.A.413/19.659;3ips.B.413/19.621;3ipu.A.413/19.646;3ipu.B.413/19.729;5avi.A.413/19.505;5avi.C.413/19.446;5avl.A.413/19.611;1uhl.B.413/18.982	3ipq.A.434/35.348;3ips.A.434/35.055;3ips.B.434/35.125;3ipu.A.434/34.779;3ipu.B.434/34.751;5avi.A.434/35.08;5avi.C.434/34.995;5avl.A.434/34.908;1uhl.B.434/32.521	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
380	R	none	none	none	none	-	147	0.536	alpha-helix	Helices	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ipq.A.413/22.584;3ips.A.413/22.479;3ips.B.413/22.475;3ipu.A.413/22.53;3ipu.B.413/22.626;5avi.A.413/22.407;5avi.C.413/22.354;5avl.A.413/22.469;1uhl.B.413/21.932	3ipq.A.434/38.187;3ips.A.434/37.96;3ips.B.434/38.084;3ipu.A.434/37.791;3ipu.B.434/37.718;5avi.A.434/38.122;5avi.C.434/38.048;5avl.A.434/37.979;1uhl.B.434/35.234	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
381	L	L>M	L>M (exome, AC = 1, AN = 251190, AF = 3.98105e-06)	none	none	-	18	0.09	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/21.619;3ips.A.413/21.68;3ips.B.413/21.579;3ipu.A.413/21.64;3ipu.B.413/21.78;5avi.A.413/21.626;5avi.C.413/21.581;5avl.A.413/21.699;1uhl.B.413/21.649	3ipq.A.434/36.031;3ips.A.434/35.891;3ips.B.434/35.99;3ipu.A.434/35.667;3ipu.B.434/35.709;5avi.A.434/36.092;5avi.C.434/36.061;5avl.A.434/35.92;1uhl.B.434/33.796	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
382	Q	none	none	none	none	B:382:GLN-N/3.81-A:409:MET;B:382:GLN-N/3.8-A:409:MET;B:382:GLN-N/3.43-A:409:MET;B:382:GLN-N/3.7-A:409:MET;C:382:GLN-N/3.53-A:409:MET;B:218:GLN-N/3.66-A:245:MET;B:218:GLN-N/3.71-A:245:MET;B:218:GLN-N/3.25-A:245:MET	13	0.057999999999999996	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/17.972;3ips.A.413/18.082;3ips.B.413/17.897;3ipu.A.413/17.945;3ipu.B.413/18.094;5avi.A.413/17.902;5avi.C.413/17.879;5avl.A.413/17.987;1uhl.B.413/17.981	3ipq.A.434/34.555;3ips.A.434/34.517;3ips.B.434/34.556;3ipu.A.434/34.148;3ipu.B.434/34.119;5avi.A.434/34.564;5avi.C.434/34.52;5avl.A.434/34.331;1uhl.B.434/32.362	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
383	H	none	none	none	none	B:383:HIS-N/3.87-A:402:LEU;B:383:HIS-N/3.6-A:402:LEU;B:383:HIS-N/3.86-A:402:LEU;B:383:HIS-N/3.65-A:406:ARG;B:383:HIS-N/3.24-A:406:ARG;B:383:HIS-N/3.34-A:406:ARG;B:383:HIS-N/3.5-A:406:ARG;B:383:HIS-N/3.5-A:406:ARG;B:383:HIS-N/3.8-A:406:ARG;B:383:HIS-N/3.85-A:402:LEU;B:383:HIS-N/3.9-A:402:LEU;B:383:HIS-N/3.68-A:406:ARG;B:383:HIS-N/3.58-A:406:ARG;B:383:HIS-N/3.69-A:406:ARG;B:383:HIS-N/3.81-A:406:ARG;C:383:HIS-N/3.83-A:402:LEU;C:383:HIS-N/3.56-A:402:LEU;C:383:HIS-N/3.83-A:402:LEU;C:383:HIS-N/3.65-A:406:ARG;C:383:HIS-N/3.45-A:406:ARG;C:383:HIS-N/3.69-A:406:ARG;C:383:HIS-N/3.74-A:406:ARG;B:219:HIS-N/3.57-A:238:LEU;B:219:HIS-N/3.81-A:238:LEU;B:219:HIS-N/3.68-A:242:ARG;B:219:HIS-N/3.42-A:242:ARG;B:219:HIS-N/3.54-A:242:ARG;B:219:HIS-N/3.84-A:242:ARG;B:219:HIS-N/3.57-A:242:ARG	25	0.11199999999999999	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/19.477;3ips.A.413/19.606;3ips.B.413/19.323;3ipu.A.413/19.444;3ipu.B.413/19.434;5avi.A.413/19.238;5avi.C.413/19.202;5avl.A.413/19.309;1uhl.B.413/19.549	3ipq.A.434/38.149;3ips.A.434/38.124;3ips.B.434/38.128;3ipu.A.434/37.756;3ipu.B.434/37.624;5avi.A.434/38.091;5avi.C.434/38.056;5avl.A.434/37.819;1uhl.B.434/35.964	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
384	T	T>A	T>A (exome, AC = 1, AN = 251244, AF = 3.98019e-06)	none	none	-	62	0.36	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/21.783;3ips.A.413/21.943;3ips.B.413/21.778;3ipu.A.413/21.747;3ipu.B.413/21.825;5avi.A.413/21.667;5avi.C.413/21.579;5avl.A.413/21.745;1uhl.B.413/21.77	3ipq.A.434/39.202;3ips.A.434/39.181;3ips.B.434/39.267;3ipu.A.434/38.893;3ipu.B.434/38.9;5avi.A.434/39.323;5avi.C.434/39.212;5avl.A.434/39.079;1uhl.B.434/37.094	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
385	Y	none	none	none	none	-	1	0.004	alpha-helix	Helices	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/19.01;3ips.A.413/19.164;3ips.B.413/19.172;3ipu.A.413/19.012;3ipu.B.413/19.029;5avi.A.413/19.062;5avi.C.413/18.935;5avl.A.413/19.039;1uhl.B.413/19.072	3ipq.A.434/36.571;3ips.A.434/36.6;3ips.B.434/36.733;3ipu.A.434/36.346;3ipu.B.434/36.333;5avi.A.434/36.786;5avi.C.434/36.676;5avl.A.434/36.434;1uhl.B.434/34.811	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
386	V	none	none	none	none	B:386:VAL-N/3.72-A:405:PRO;B:386:VAL-N/3.62-A:405:PRO;B:386:VAL-N/3.89-A:405:PRO;C:386:VAL-N/3.8-A:405:PRO;C:386:VAL-N/3.81-A:405:PRO;B:222:VAL-N/3.63-A:241:PRO;B:222:VAL-N/3.78-A:241:PRO	2	0.011000000000000001	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/17.298;3ips.A.413/17.154;3ips.B.413/17.179;3ipu.A.413/17.177;3ipu.B.413/17.216;5avi.A.413/17.155;5avi.C.413/16.998;5avl.A.413/17.118;1uhl.B.413/17.217	3ipq.A.434/37.669;3ips.A.434/37.452;3ips.B.434/37.547;3ipu.A.434/37.345;3ipu.B.434/37.32;5avi.A.434/37.68;5avi.C.434/37.523;5avl.A.434/37.318;1uhl.B.434/35.628	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
387	E	none	none	none	none	B:387:GLU-N/3.8-A:402:LEU;B:387:GLU-N/3.84-A:402:LEU;B:387:GLU-N/3.8-A:402:LEU;B:387:GLU-N/3.7-A:402:LEU;B:223:GLU-N/3.85-A:238:LEU	78	0.35	alpha-helix	Helices	Medium-buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/20.792;3ips.A.413/20.605;3ips.B.413/20.579;3ipu.A.413/20.641;3ipu.B.413/20.706;5avi.A.413/20.625;5avi.C.413/20.312;5avl.A.413/20.519;1uhl.B.413/20.49	3ipq.A.434/41.28;3ips.A.434/41.108;3ips.B.434/41.217;3ipu.A.434/41.01;3ipu.B.434/41.015;5avi.A.434/41.391;5avi.C.434/41.236;5avl.A.434/40.98;1uhl.B.434/39.364	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
388	A	A>T	A>T (exome, AC = 3, AN = 251192, AF = 1.19431e-05)	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/21.436;3ips.A.413/21.388;3ips.B.413/21.52;3ipu.A.413/21.374;3ipu.B.413/21.505;5avi.A.413/21.323;5avi.C.413/21.266;5avl.A.413/21.36;1uhl.B.413/21.497	3ipq.A.434/40.488;3ips.A.434/40.375;3ips.B.328/40.447;3ipu.A.328/40.243;3ipu.B.434/40.463;5avi.A.328/40.331;5avi.C.328/40.342;5avl.A.328/40.156;1uhl.B.434/39.096	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
389	L	L>P	L>P (exome, AC = 1, AN = 251224, AF = 3.98051e-06)	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/18.36;3ips.A.413/18.421;3ips.B.413/18.437;3ipu.A.413/18.334;3ipu.B.413/18.381;5avi.A.413/18.183;5avi.C.413/18.227;5avl.A.413/18.303;1uhl.B.413/18.579	3ipq.A.328/38.488;3ips.A.328/37.718;3ips.B.328/37.628;3ipu.A.328/37.485;3ipu.B.328/37.67;5avi.A.328/37.551;5avi.C.328/37.546;5avl.A.328/37.361;1uhl.B.434/37.508	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
390	H	none	none	none	none	-	29	0.129	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/19.441;3ips.A.413/19.482;3ips.B.413/19.408;3ipu.A.413/19.268;3ipu.B.413/19.399;5avi.A.413/19.414;5avi.C.413/19.346;5avl.A.413/19.282;1uhl.B.413/19.254	3ipq.A.328/41.013;3ips.A.328/40.339;3ips.B.328/40.174;3ipu.A.328/40.036;3ipu.B.328/40.224;5avi.A.328/40.288;5avi.C.328/40.201;5avl.A.328/39.899;1uhl.B.434/40.061	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
391	A	A>V	A>V (exome, AC = 1, AN = 251200, AF = 3.98089e-06)	none	none	-	6	0.047	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/23.006;3ips.A.413/23.023;3ips.B.413/22.935;3ipu.A.413/22.8;3ipu.B.413/22.987;5avi.A.413/22.894;5avi.C.413/22.895;5avl.A.413/22.836;1uhl.B.413/22.805	3ipq.A.328/43.457;3ips.A.328/42.75;3ips.B.328/42.593;3ipu.A.328/42.432;3ipu.B.328/42.744;5avi.A.328/42.56;5avi.C.328/42.609;5avl.A.328/42.329;1uhl.B.434/42.74	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
392	Y	Y>D	Y>D (exome, AC = 1, AN = 251186, AF = 3.98111e-06)	none	none	-	49	0.18600000000000003	alpha-helix	Helices	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/22.252;3ips.A.413/22.28;3ips.B.413/22.263;3ipu.A.413/22.082;3ipu.B.413/22.135;5avi.A.413/22.042;5avi.C.413/22.113;5avl.A.413/22.017;1uhl.B.413/22.232	3ipq.A.328/40.899;3ips.A.328/40.215;3ips.B.328/40.139;3ipu.A.328/39.904;3ipu.B.328/40.129;5avi.A.328/39.909;5avi.C.328/40.005;5avl.A.328/39.702;1uhl.B.328/40.741	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
393	V	none	none	none	none	-	3	0.017	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/20.157;3ips.A.413/20.169;3ips.B.413/20.168;3ipu.A.413/19.984;3ipu.B.413/20.033;5avi.A.413/20.1;5avi.C.413/20.086;5avl.A.413/20.018;1uhl.B.413/20.365	3ipq.A.328/39.434;3ips.A.328/38.79;3ips.B.328/38.732;3ipu.A.328/38.562;3ipu.B.328/38.746;5avi.A.328/38.712;5avi.C.328/38.723;5avl.A.328/38.36;1uhl.B.328/39.539	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
394	S	S>C	S>C (exome, AC = 1, AN = 251202, AF = 3.98086e-06)	none	none	-	52	0.335	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/23.052;3ips.A.413/23.05;3ips.B.413/23.076;3ipu.A.413/23.037;3ipu.B.413/22.993;5avi.A.413/23.108;5avi.C.413/23.112;5avl.A.413/22.981;1uhl.B.413/22.987	3ipq.A.328/43.028;3ips.A.328/42.425;3ips.B.328/42.371;3ipu.A.328/42.247;3ipu.B.328/42.397;5avi.A.328/42.437;5avi.C.328/42.44;5avl.A.328/42.025;1uhl.B.328/43.056	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
395	I	none	none	none	none	-	103	0.523	alpha-helix	Helices	Medium-exposed	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.306/25.187;3ips.A.306/24.817;3ips.B.306/25.187;3ipu.A.306/24.905;3ipu.B.306/25.105;5avi.A.306/25.007;5avi.C.306/24.823;5avl.A.306/24.841;1uhl.B.413/25.632	3ipq.A.328/43.398;3ips.A.328/42.746;3ips.B.328/42.788;3ipu.A.328/42.538;3ipu.B.328/42.753;5avi.A.328/42.65;5avi.C.328/42.603;5avl.A.328/42.462;1uhl.B.328/44.131	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
396	H	none	none	none	none	-	72	0.321	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.306/21.579;3ips.A.306/21.273;3ips.B.306/21.616;3ipu.A.306/21.311;3ipu.B.306/21.539;5avi.A.306/21.388;5avi.C.306/21.209;5avl.A.306/21.243;1uhl.B.306/23.417	3ipq.A.328/39.97;3ips.A.328/39.453;3ips.B.328/39.476;3ipu.A.328/39.187;3ipu.B.328/39.442;5avi.A.328/39.261;5avi.C.328/39.221;5avl.A.328/39.103;1uhl.B.328/41.27	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
397	H	none	none	none	none	-	48	0.214	bend	coils	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.306/22.231;3ips.A.306/21.925;3ips.B.306/22.059;3ipu.A.306/21.906;3ipu.B.306/22.002;5avi.A.306/21.948;5avi.C.306/21.792;5avl.A.306/21.831;1uhl.B.413/22.37	3ipq.A.328/40.367;3ips.A.328/40.003;3ips.B.328/39.774;3ipu.A.328/39.663;3ipu.B.328/39.837;5avi.A.328/39.725;5avi.C.328/39.7;5avl.A.328/39.588;1uhl.B.328/40.134	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
398	P	none	none	none	none	-	83	0.522	turn	coils	Medium-exposed	Special	-	-	-	-	3ipq.A.413/25.263;3ips.A.413/25.253;3ips.B.413/25.12;3ipu.A.413/24.966;3ipu.B.413/25.094;5avi.A.413/25.046;5avi.C.413/25.048;5avl.A.413/25.146;1uhl.B.413/25.208	3ipq.A.328/44.113;3ips.A.328/43.756;3ips.B.328/43.55;3ipu.A.328/43.447;3ipu.B.328/43.6;5avi.A.328/43.496;5avi.C.328/43.485;5avl.A.328/43.372;1uhl.B.328/43.762	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
399	H	H>Q	H>Q (exome, AC = 84, AN = 251234, AF = 0.00033435); H>Q (genome, AC = 2, AN = 31386, AF = 6.37227e-05)	none	none	-	186	0.83	turn	coils	exposed	Positively Charged & Polar	-	-	-	-	3ipq.A.413/25.173;3ips.A.413/25.148;3ips.B.413/24.884;3ipu.A.413/24.941;3ipu.B.413/25.082;5avi.A.413/25.12;5avi.C.413/25.14;5avl.A.413/25.095;1uhl.B.413/24.583	3ipq.A.328/44.281;3ips.A.328/43.982;3ips.B.328/43.647;3ipu.A.328/43.664;3ipu.B.328/43.843;5avi.A.328/43.81;5avi.C.328/43.797;5avl.A.328/43.578;1uhl.B.328/42.98	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
400	D	none	none	none	none	-	60	0.311	loop	coils	Medium-buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.413/21.486;3ips.A.413/21.428;3ips.B.413/21.198;3ipu.A.413/21.23;3ipu.B.413/21.393;5avi.A.413/21.401;5avi.C.413/21.434;5avl.A.413/21.433;1uhl.B.413/20.809	3ipq.A.328/41.361;3ips.A.328/40.989;3ips.B.328/40.562;3ipu.A.328/40.708;3ipu.B.328/41.006;5avi.A.328/40.848;5avi.C.328/40.879;5avl.A.328/40.637;1uhl.B.328/39.865	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
401	R	R>P	R>P (exome, AC = 2, AN = 251386, AF = 7.95589e-06)	none	none	B:401:ARG-N/3.49-A:390:HIS;A:401:ARG-H/3.27-B:205:GLN	152	0.555	turn	coils	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ipq.A.413/20.301;3ips.A.413/20.374;3ips.B.413/20.349;3ipu.A.413/20.165;3ipu.B.413/20.134;5avi.A.413/20.26;5avi.C.413/20.302;5avl.A.413/20.356;1uhl.B.413/19.884	3ipq.A.328/42.029;3ips.A.328/41.763;3ips.B.328/41.507;3ipu.A.328/41.459;3ipu.B.328/41.518;5avi.A.328/41.528;5avi.C.328/41.584;5avl.A.328/41.367;1uhl.B.328/40.762	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
402	L	none	none	none	none	B:402:LEU-N/3.88-A:383:HIS;B:402:LEU-N/3.85-A:383:HIS;B:402:LEU-N/3.53-A:383:HIS;B:402:LEU-N/3.72-A:383:HIS;B:402:LEU-N/3.84-A:387:GLU;B:402:LEU-N/3.83-A:383:HIS;B:402:LEU-N/3.78-A:383:HIS;B:402:LEU-N/3.77-A:383:HIS;B:402:LEU-N/3.9-A:383:HIS;B:402:LEU-N/3.57-A:387:GLU;B:402:LEU-N/3.32-A:387:GLU;C:402:LEU-N/3.75-A:383:HIS;C:402:LEU-N/3.83-A:383:HIS;C:402:LEU-N/3.81-A:383:HIS;C:402:LEU-N/3.84-A:387:GLU;C:402:LEU-N/3.88-A:387:GLU;C:402:LEU-N/3.88-A:387:GLU;C:402:LEU-N/3.74-A:387:GLU;B:238:LEU-N/3.75-A:219:HIS;B:238:LEU-N/3.62-A:219:HIS;B:238:LEU-N/3.83-A:219:HIS;B:238:LEU-N/3.77-A:223:GLU;B:238:LEU-N/3.82-A:223:GLU	26	0.129	turn	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/16.925;3ips.A.413/16.912;3ips.B.413/16.856;3ipu.A.413/16.809;3ipu.B.413/16.771;5avi.A.413/16.875;5avi.C.413/16.945;5avl.A.413/17.019;1uhl.B.413/16.644	3ipq.A.328/38.883;3ips.A.328/38.559;3ips.B.328/38.333;3ipu.A.328/38.335;3ipu.B.328/38.406;5avi.A.328/38.502;5avi.C.328/38.563;5avl.A.328/38.359;1uhl.B.328/38.293	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
403	M	none	none	none	none	-	8	0.036000000000000004	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/15.868;3ips.A.413/15.81;3ips.B.413/15.842;3ipu.A.413/15.715;3ipu.B.413/15.737;5avi.A.413/15.824;5avi.C.413/15.823;5avl.A.413/15.864;1uhl.B.413/15.329	3ipq.A.328/36.544;3ips.A.328/36.029;3ips.B.328/35.953;3ipu.A.328/35.857;3ipu.B.328/36.001;5avi.A.328/36.03;5avi.C.328/36.047;5avl.A.328/35.843;1uhl.B.328/35.555	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
404	F	none	none	none	none	-	4	0.017	alpha-helix	Helices	core	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/15.365;3ips.A.413/15.241;3ips.B.413/15.399;3ipu.A.413/15.242;3ipu.B.413/15.328;5avi.A.413/15.258;5avi.C.413/15.229;5avl.A.413/15.36;1uhl.B.413/14.743	3ipq.A.328/37.365;3ips.A.328/36.672;3ips.B.328/36.695;3ipu.A.328/36.589;3ipu.B.328/36.781;5avi.A.328/36.659;5avi.C.328/36.652;5avl.A.328/36.537;1uhl.B.328/36.533	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
405	P	P>S	P>S (exome, AC = 1, AN = 251390, AF = 3.97788e-06)	none	none	B:405:PRO-N/3.54-A:386:VAL;B:405:PRO-N/3.58-A:386:VAL;B:405:PRO-N/3.74-A:386:VAL;B:405:PRO-N/3.69-A:408:LEU;C:405:PRO-N/3.81-A:386:VAL;C:405:PRO-N/3.82-A:386:VAL;C:405:PRO-N/3.82-A:408:LEU;B:241:PRO-N/3.56-A:222:VAL;B:241:PRO-N/3.68-A:222:VAL;B:241:PRO-N/3.89-A:240:PHE;B:241:PRO-N/3.52-A:244:LEU	2	0.013000000000000001	alpha-helix	Helices	core	Special	-	-	-	-	3ipq.A.413/13.123;3ips.A.413/12.891;3ips.B.413/13.016;3ipu.A.413/12.908;3ipu.B.413/13.019;5avi.A.413/12.867;5avi.C.413/12.851;5avl.A.413/13.129;1uhl.B.413/12.533	3ipq.A.328/36.789;3ips.A.328/36.087;3ips.B.328/35.995;3ipu.A.328/35.988;3ipu.B.328/36.172;5avi.A.328/36.029;5avi.C.328/36.025;5avl.A.328/36.014;1uhl.B.328/36.071	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
406	R	none	none	none	none	B:406:ARG-N/3.71-A:383:HIS;B:406:ARG-N/3.86-A:383:HIS;B:406:ARG-N/3.41-A:383:HIS;B:406:ARG-N/3.66-A:383:HIS;B:406:ARG-N/3.8-A:383:HIS;B:406:ARG-N/3.69-A:383:HIS;B:406:ARG-N/3.77-A:383:HIS;B:406:ARG-N/3.46-A:383:HIS;B:406:ARG-N/3.88-A:383:HIS;C:406:ARG-N/3.65-A:383:HIS;C:406:ARG-N/3.73-A:383:HIS;C:406:ARG-N/3.61-A:383:HIS;C:406:ARG-N/3.5-A:383:HIS;B:242:ARG-N/3.72-A:219:HIS;B:242:ARG-N/3.54-A:219:HIS;B:242:ARG-N/3.55-A:219:HIS;B:242:ARG-N/3.48-A:219:HIS;B:242:ARG-N/3.85-A:219:HIS	50	0.182	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/11.124;3ips.A.413/11.118;3ips.B.413/11.13;3ipu.A.413/10.876;3ipu.B.413/10.993;5avi.A.413/10.9;5avi.C.413/10.925;5avl.A.413/11.065;1uhl.B.413/10.961	3ipq.A.328/33.641;3ips.A.328/33.132;3ips.B.328/32.98;3ipu.A.328/32.88;3ipu.B.328/33.071;5avi.A.328/32.928;5avi.C.328/32.932;5avl.A.328/32.866;1uhl.B.328/33.139	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
407	M	M>I	M>I (exome, AC = 12, AN = 251412, AF = 4.77304e-05); M>I (genome, AC = 1, AN = 31400, AF = 3.18471e-05)	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/10.565;3ips.A.413/10.645;3ips.B.413/10.533;3ipu.A.413/10.397;3ipu.B.413/10.467;5avi.A.413/10.311;5avi.C.413/10.295;5avl.A.413/10.476;1uhl.B.413/10.209	3ipq.A.328/32.169;3ips.A.328/31.623;3ips.B.328/31.431;3ipu.A.328/31.302;3ipu.B.328/31.504;5avi.A.328/31.313;5avi.C.328/31.259;5avl.A.328/31.194;1uhl.B.328/31.423	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
408	L	none	none	none	none	B:408:LEU-N/3.7-A:405:PRO;B:408:LEU-N/3.89-A:405:PRO;C:408:LEU-N/3.8-A:405:PRO;B:244:LEU-N/3.64-A:241:PRO	2	0.01	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/9.762;3ips.A.413/9.665;3ips.B.413/9.582;3ipu.A.413/9.655;3ipu.B.413/9.546;5avi.A.413/9.334;5avi.C.413/9.415;5avl.A.413/9.499;1uhl.B.413/9.807	3ipq.A.328/33.341;3ips.A.328/32.639;3ips.B.328/32.403;3ipu.A.328/32.491;3ipu.B.328/32.534;5avi.A.328/32.47;5avi.C.328/32.51;5avl.A.328/32.261;1uhl.B.434/32.447	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
409	M	M>I	M>I (exome, AC = 1, AN = 251430, AF = 3.97725e-06)	none	none	B:409:MET-N/3.79-A:362:ILE;B:409:MET-N/3.82-A:382:GLN;B:409:MET-N/3.8-A:362:ILE;B:409:MET-N/3.33-A:382:GLN;C:409:MET-N/3.87-A:362:ILE;C:409:MET-N/3.73-A:382:GLN;B:245:MET-N/3.63-A:198:ILE;B:245:MET-N/3.49-A:218:GLN;B:245:MET-N/3.8-A:247:LEU	18	0.08	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/7.16;3ips.A.413/7.154;3ips.B.413/6.99;3ipu.A.413/7.037;3ipu.B.413/6.888;5avi.A.413/6.857;5avi.C.413/6.909;5avl.A.413/6.971;1uhl.B.413/6.985	3ipq.A.328/31.882;3ips.A.328/31.46;3ips.B.328/31.071;3ipu.A.328/31.15;3ipu.B.328/31.1;5avi.A.328/31.138;5avi.C.328/31.176;5avl.A.328/30.978;1uhl.B.328/31.43	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
410	K	none	none	none	none	A:410:LYS-S/3.96-C:379:GLU	23	0.09699999999999999	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/5.119;3ips.A.413/5.238;3ips.B.413/5.159;3ipu.A.413/5.03;3ipu.B.413/5.076;5avi.A.413/4.972;5avi.C.413/5.005;5avl.A.413/5.144;1uhl.B.413/4.899	3ipq.A.328/28.312;3ips.A.328/27.838;3ips.B.328/27.584;3ipu.A.328/27.527;3ipu.B.328/27.583;5avi.A.328/27.579;5avi.C.328/27.592;5avl.A.328/27.48;1uhl.B.328/27.765	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
411	L	none	none	none	none	B:411:LEU-N/3.89-A:409:MET;B:411:LEU-N/3.63-A:409:MET;B:411:LEU-N/3.77-A:409:MET;B:411:LEU-N/3.7-A:412:VAL;C:411:LEU-N/3.47-A:412:VAL;B:247:LEU-N/3.83-A:245:MET;B:247:LEU-N/3.52-A:248:VAL	4	0.02	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/5.454;3ips.A.413/5.474;3ips.B.413/5.475;3ipu.A.413/5.465;3ipu.B.413/5.537;5avi.A.413/5.309;5avi.C.413/5.331;5avl.A.413/5.435;1uhl.B.413/5.505	3ipq.A.328/28.934;3ips.A.328/28.313;3ips.B.328/28.003;3ipu.A.328/28.005;3ipu.B.328/28.224;5avi.A.328/28.09;5avi.C.328/28.1;5avl.A.328/28.011;1uhl.B.434/26.748	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
412	V	none	none	none	none	B:412:VAL-N/3.9-A:411:LEU;B:412:VAL-N/3.72-A:412:VAL;B:412:VAL-N/3.87-A:412:VAL;B:412:VAL-N/3.69-A:415:ARG;B:412:VAL-N/3.46-A:415:ARG;B:412:VAL-N/3.4-A:415:ARG;B:412:VAL-N/3.35-A:415:ARG;B:412:VAL-N/3.37-A:415:ARG;B:412:VAL-N/3.72-A:411:LEU;B:412:VAL-N/3.62-A:412:VAL;B:412:VAL-N/3.41-A:415:ARG;B:412:VAL-N/3.29-A:415:ARG;B:412:VAL-N/3.35-A:415:ARG;B:412:VAL-N/3.47-A:415:ARG;B:412:VAL-N/3.69-A:415:ARG;C:412:VAL-N/3.59-A:411:LEU;C:412:VAL-N/3.81-A:412:VAL;C:412:VAL-N/3.46-A:415:ARG;C:412:VAL-N/3.77-A:415:ARG;C:412:VAL-N/3.73-A:415:ARG;C:412:VAL-N/3.68-A:415:ARG;C:412:VAL-N/3.79-A:415:ARG;C:412:VAL-N/3.73-A:415:ARG;B:248:VAL-N/3.7-A:247:LEU;B:248:VAL-N/3.72-A:248:VAL;B:248:VAL-N/3.44-A:251:ARG;B:248:VAL-N/3.46-A:251:ARG;B:248:VAL-N/3.54-A:251:ARG;B:248:VAL-N/3.52-A:251:ARG;B:248:VAL-N/3.65-A:251:ARG	6	0.034	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/3.85;3ips.A.413/3.848;3ips.B.413/3.836;3ipu.A.413/3.836;3ipu.B.413/3.853;5avi.A.413/3.853;5avi.C.413/3.849;5avl.A.413/3.856;1uhl.B.413/3.755	3ipq.A.328/29.218;3ips.A.328/28.812;3ips.B.328/28.443;3ipu.A.328/28.503;3ipu.B.328/28.626;5avi.A.328/28.769;5avi.C.328/28.774;5avl.A.328/28.524;1uhl.B.434/27.237	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
413	S	none	none	none	none	B:413:SER-H/2.69-A:368:ASP;A:413:SER-H/2.78-B:368:ASP;B:413:SER-N/3.47-A:368:ASP;B:413:SER-N/3.53-A:368:ASP;B:413:SER-N/3.46-A:368:ASP;B:413:SER-N/2.69-A:368:ASP;B:413:SER-H/3.11-A:368:ASP;A:413:SER-H/2.89-B:368:ASP;B:413:SER-N/3.84-A:368:ASP;B:413:SER-N/3.6-A:368:ASP;B:413:SER-N/3.68-A:368:ASP;B:413:SER-N/3.11-A:368:ASP;C:413:SER-H/2.71-A:368:ASP;A:413:SER-H/2.81-C:368:ASP;C:413:SER-N/3.69-A:368:ASP;C:413:SER-N/3.24-A:368:ASP;C:413:SER-N/3.55-A:368:ASP;C:413:SER-N/3.42-A:368:ASP;C:413:SER-N/2.71-A:368:ASP;B:249:SER-H/2.92-A:204:ASP;A:249:SER-H/2.91-B:204:ASP;B:249:SER-N/3.7-A:204:ASP;B:249:SER-N/3.51-A:204:ASP;B:249:SER-N/3.54-A:204:ASP;B:249:SER-N/2.92-A:204:ASP	17	0.11	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/0.0;3ips.A.413/0.0;3ips.B.413/0.0;3ipu.A.413/0.0;3ipu.B.413/0.0;5avi.A.413/0.0;5avi.C.413/0.0;5avl.A.413/0.0;1uhl.B.413/0.0	3ipq.A.328/25.695;3ips.A.328/25.336;3ips.B.328/25.018;3ipu.A.328/25.117;3ipu.B.328/25.172;5avi.A.328/25.323;5avi.C.328/25.31;5avl.A.328/25.073;1uhl.B.328/25.459	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
414	L	L>F	L>F (exome, AC = 1, AN = 251464, AF = 3.97671e-06)	none	none	-	0	0	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/3.785;3ips.A.413/3.859;3ips.B.413/3.833;3ipu.A.413/3.821;3ipu.B.413/3.784;5avi.A.413/3.799;5avi.C.413/3.83;5avl.A.413/3.808;1uhl.B.413/3.752	3ipq.A.328/24.43;3ips.A.328/23.767;3ips.B.328/23.468;3ipu.A.328/23.597;3ipu.B.328/23.603;5avi.A.328/23.784;5avi.C.328/23.727;5avl.A.328/23.663;1uhl.B.434/22.938	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
415	R	R>W; R>Q	R>W (exome, AC = 1, AN = 251458, AF = 3.97681e-06); R>Q (exome, AC = 55, AN = 251450, AF = 0.000218731); R>Q (genome, AC = 6, AN = 31390, AF = 0.000191144)	R>Q	R>Q (ClinVar, phenotype = Multiple sclerosis); R>Q (ClinVar, phenotype = Multiple sclerosis)	A:415:ARG-H/2.88-B:416:THR;B:415:ARG-H/3.08-A:416:THR;B:415:ARG-N/3.89-A:412:VAL;B:415:ARG-N/3.31-A:412:VAL;B:415:ARG-N/3.34-A:412:VAL;B:415:ARG-N/3.24-A:412:VAL;B:415:ARG-N/3.3-A:412:VAL;B:415:ARG-N/3.37-A:412:VAL;B:415:ARG-N/3.75-A:415:ARG;B:415:ARG-N/3.78-A:416:THR;B:415:ARG-N/3.35-A:416:THR;B:415:ARG-N/3.08-A:416:THR;A:415:ARG-H/2.92-B:416:THR;B:415:ARG-H/3.05-A:416:THR;B:415:ARG-N/3.55-A:412:VAL;B:415:ARG-N/3.51-A:412:VAL;B:415:ARG-N/3.45-A:412:VAL;B:415:ARG-N/3.66-A:412:VAL;B:415:ARG-N/3.7-A:412:VAL;B:415:ARG-N/3.65-A:415:ARG;B:415:ARG-N/3.88-A:416:THR;B:415:ARG-N/3.43-A:416:THR;B:415:ARG-N/3.05-A:416:THR;A:415:ARG-H/2.81-C:416:THR;C:415:ARG-H/2.79-A:416:THR;C:415:ARG-N/3.43-A:412:VAL;C:415:ARG-N/3.7-A:412:VAL;C:415:ARG-N/3.76-A:412:VAL;C:415:ARG-N/3.7-A:412:VAL;C:415:ARG-N/3.69-A:412:VAL;C:415:ARG-N/3.77-A:412:VAL;C:415:ARG-N/3.82-A:415:ARG;C:415:ARG-N/3.87-A:416:THR;C:415:ARG-N/3.86-A:416:THR;C:415:ARG-N/3.76-A:416:THR;C:415:ARG-N/3.44-A:416:THR;C:415:ARG-N/3.85-A:416:THR;C:415:ARG-N/2.79-A:416:THR;A:251:ARG-H/2.74-B:252:THR;B:251:ARG-H/3.11-A:252:THR;B:251:ARG-N/3.58-A:248:VAL;B:251:ARG-N/3.54-A:248:VAL;B:251:ARG-N/3.62-A:248:VAL;B:251:ARG-N/3.69-A:248:VAL;B:251:ARG-N/3.82-A:248:VAL;B:251:ARG-N/3.69-A:251:ARG;B:251:ARG-N/3.45-A:252:THR;B:251:ARG-N/3.11-A:252:THR	12	0.044000000000000004	alpha-helix	Helices	core	Positively Charged & Polar	-	-	-	-	3ipq.A.413/5.345;3ips.A.413/5.484;3ips.B.413/5.511;3ipu.A.413/5.474;3ipu.B.413/5.405;5avi.A.413/5.56;5avi.C.413/5.521;5avl.A.413/5.394;1uhl.B.413/5.325	3ipq.A.434/24.43;3ips.A.434/24.202;3ips.B.434/24.355;3ipu.A.434/24.144;3ipu.B.434/23.911;5avi.A.434/23.999;5avi.C.434/24.023;5avl.A.434/24.001;1uhl.B.434/22.196	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
416	T	T>I	T>I (exome, AC = 1, AN = 251472, AF = 3.97659e-06)	none	none	B:416:THR-N/3.43-A:415:ARG;B:416:THR-N/3.88-A:415:ARG;B:416:THR-N/3.71-A:415:ARG;B:416:THR-N/2.88-A:415:ARG;B:416:THR-N/3.8-A:415:ARG;B:416:THR-N/3.66-A:415:ARG;B:416:THR-N/2.92-A:415:ARG;C:416:THR-N/3.76-A:415:ARG;C:416:THR-N/3.43-A:415:ARG;C:416:THR-N/3.87-A:415:ARG;C:416:THR-N/2.81-A:415:ARG;B:252:THR-N/3.64-A:251:ARG;B:252:THR-N/3.32-A:251:ARG;B:252:THR-N/3.79-A:251:ARG;B:252:THR-N/3.76-A:251:ARG;B:252:THR-N/2.74-A:251:ARG	50	0.29100000000000004	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/5.304;3ips.A.413/5.338;3ips.B.413/5.293;3ipu.A.413/5.356;3ipu.B.413/5.347;5avi.A.413/5.53;5avi.C.413/5.486;5avl.A.413/5.273;1uhl.B.413/5.317	3ipq.A.434/23.975;3ips.A.328/23.503;3ips.B.328/23.367;3ipu.A.328/23.424;3ipu.B.434/23.441;5avi.A.328/23.478;5avi.C.328/23.493;5avl.A.328/23.4;1uhl.B.434/21.746	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
417	L	none	none	none	none	-	8	0.04	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/6.271;3ips.A.413/6.468;3ips.B.413/6.44;3ipu.A.413/6.452;3ipu.B.413/6.317;5avi.A.413/6.594;5avi.C.413/6.453;5avl.A.413/6.34;1uhl.B.413/6.447	3ipq.A.328/20.885;3ips.A.328/20.117;3ips.B.328/19.91;3ipu.A.328/19.971;3ipu.B.328/20.131;5avi.A.328/20.031;5avi.C.328/20.115;5avl.A.328/20.024;1uhl.B.434/19.543	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
418	S	S>R	S>R (exome, AC = 1, AN = 251486, AF = 3.97636e-06); S>R (genome, AC = 1, AN = 31398, AF = 3.18492e-05)	none	none	-	22	0.142	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/8.73;3ips.A.413/8.689;3ips.B.413/8.737;3ipu.A.413/8.802;3ipu.B.413/8.623;5avi.A.413/8.878;5avi.C.413/8.822;5avl.A.413/8.681;1uhl.B.413/8.696	3ipq.A.434/19.323;3ips.A.434/19.43;3ips.B.434/19.442;3ipu.A.434/19.153;3ipu.B.434/19.028;5avi.A.434/19.134;5avi.C.434/19.157;5avl.A.434/19.127;1uhl.B.434/17.179	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
419	S	S>R; S>N	S>R (exome, AC = 1, AN = 251488, AF = 3.97633e-06); S>N (exome, AC = 2, AN = 251488, AF = 7.95267e-06); S>R (exome, AC = 12, AN = 251476, AF = 4.77183e-05); S>N (genome, AC = 1, AN = 31400, AF = 3.18471e-05)	none	none	A:419:SER-H/2.63-B:419:SER;B:419:SER-N/3.23-A:419:SER;B:419:SER-N/3.88-A:419:SER;B:419:SER-N/2.63-A:419:SER;A:419:SER-H/3.33-B:419:SER;B:419:SER-H/3.33-A:419:SER;B:419:SER-N/3.73-A:419:SER;B:419:SER-N/3.78-A:419:SER;B:419:SER-N/3.33-A:419:SER;A:419:SER-H/2.88-C:419:SER;C:419:SER-H/2.88-A:419:SER;C:419:SER-N/3.86-A:419:SER;C:419:SER-N/3.42-A:419:SER;C:419:SER-N/3.42-A:419:SER;C:419:SER-N/2.88-A:419:SER;A:255:SER-H/2.69-B:255:SER;B:255:SER-H/2.69-A:255:SER;B:255:SER-N/3.61-A:255:SER;B:255:SER-N/3.34-A:255:SER;B:255:SER-N/2.69-A:255:SER	25	0.161	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/10.321;3ips.A.413/10.093;3ips.B.413/10.023;3ipu.A.413/10.174;3ipu.B.413/10.09;5avi.A.413/10.228;5avi.C.413/10.141;5avl.A.413/10.344;1uhl.B.413/10.098	3ipq.A.434/19.345;3ips.A.434/19.4;3ips.B.434/19.645;3ipu.A.434/19.343;3ipu.B.434/19.08;5avi.A.434/19.217;5avi.C.434/19.325;5avl.A.434/18.72;1uhl.B.434/17.112	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
420	V	V>I	V>I (exome, AC = 1, AN = 251470, AF = 3.97662e-06)	none	none	-	24	0.138	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/10.7;3ips.A.413/10.548;3ips.B.413/10.715;3ipu.A.413/10.9;3ipu.B.413/10.695;5avi.A.413/10.776;5avi.C.413/10.758;5avl.A.413/10.715;1uhl.B.413/10.808	3ipq.A.434/18.326;3ips.A.434/18.541;3ips.B.328/18.389;3ipu.A.434/18.158;3ipu.B.434/18.069;5avi.A.434/18.234;5avi.C.434/18.301;5avl.A.434/18.018;1uhl.B.434/16.554	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
421	H	none	none	none	none	-	13	0.057999999999999996	alpha-helix	Helices	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/12.361;3ips.A.413/12.401;3ips.B.413/12.389;3ipu.A.413/12.451;3ipu.B.413/12.292;5avi.A.413/12.577;5avi.C.413/12.531;5avl.A.413/12.443;1uhl.B.413/12.561	3ipq.A.434/15.267;3ips.A.434/15.368;3ips.B.434/15.454;3ipu.A.434/15.15;3ipu.B.434/15.037;5avi.A.434/15.113;5avi.C.434/15.171;5avl.A.434/14.966;1uhl.B.434/13.433	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
422	S	none	none	none	none	-	70	0.452	alpha-helix	Helices	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.413/14.614;3ips.A.413/14.57;3ips.B.413/14.591;3ipu.A.413/14.681;3ipu.B.413/14.507;5avi.A.413/14.651;5avi.C.413/14.59;5avl.A.413/14.464;1uhl.B.413/14.743	3ipq.A.434/14.505;3ips.A.434/14.574;3ips.B.434/14.68;3ipu.A.434/14.305;3ipu.B.434/14.187;5avi.A.434/14.427;5avi.C.434/14.457;5avl.A.434/14.424;1uhl.B.434/12.028	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
423	E	E>D	E>D (exome, AC = 1, AN = 251482, AF = 3.97643e-06)	none	none	-	110	0.493	alpha-helix	Helices	Medium-buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/15.746;3ips.A.413/15.814;3ips.B.413/15.865;3ipu.A.413/15.994;3ipu.B.413/15.835;5avi.A.413/15.854;5avi.C.413/15.94;5avl.A.413/15.695;1uhl.B.413/15.693	3ipq.A.434/14.865;3ips.A.434/14.824;3ips.B.434/14.911;3ipu.A.434/14.481;3ipu.B.434/14.371;5avi.A.434/14.685;5avi.C.434/14.631;5avl.A.434/14.69;1uhl.B.434/13.176	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
424	Q	none	none	none	none	-	6	0.027000000000000003	alpha-helix	Helices	core	Neutral & Polar	-	-	-	-	3ipq.A.413/16.828;3ips.A.413/16.675;3ips.B.413/16.67;3ipu.A.413/16.751;3ipu.B.413/16.627;5avi.A.413/16.896;5avi.C.413/16.895;5avl.A.413/16.572;1uhl.B.413/16.617	3ipq.A.434/12.293;3ips.A.434/12.437;3ips.B.434/12.498;3ipu.A.434/12.105;3ipu.B.434/12.011;5avi.A.434/12.115;5avi.C.434/12.159;5avl.A.434/12.119;1uhl.B.434/11.242	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
425	V	V>L	V>L (exome, AC = 3, AN = 251486, AF = 1.19291e-05)	none	none	-	10	0.057	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/18.587;3ips.A.413/18.638;3ips.B.413/18.585;3ipu.A.413/18.783;3ipu.B.413/18.583;5avi.A.413/18.861;5avi.C.413/18.838;5avl.A.413/18.6;1uhl.B.413/18.569	3ipq.A.434/9.764;3ips.A.434/9.672;3ips.B.434/9.875;3ipu.A.434/9.375;3ipu.B.434/9.287;5avi.A.434/9.425;5avi.C.434/9.423;5avl.A.434/9.431;1uhl.B.434/7.928	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
426	F	none	none	none	none	-	121	0.504	alpha-helix	Helices	Medium-exposed	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/20.322;3ips.A.413/20.356;3ips.B.413/20.304;3ipu.A.413/20.537;3ipu.B.413/20.27;5avi.A.413/20.497;5avi.C.413/20.462;5avl.A.413/20.313;1uhl.B.413/20.042	3ipq.A.434/11.104;3ips.A.434/10.835;3ips.B.434/11.136;3ipu.A.434/10.544;3ipu.B.434/10.48;5avi.A.434/10.729;5avi.C.434/10.72;5avl.A.434/10.654;1uhl.B.434/9.318	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
427	A	A>T	A>T (exome, AC = 1, AN = 251486, AF = 3.97636e-06)	none	none	-	14	0.109	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/21.463;3ips.A.246/21.07;3ips.B.246/20.595;3ipu.A.246/20.641;3ipu.B.246/21.047;5avi.A.246/21.211;5avi.C.246/21.087;5avl.A.413/21.269;1uhl.B.413/21.166	3ipq.A.434/10.909;3ips.A.434/10.906;3ips.B.434/11.159;3ipu.A.434/10.464;3ipu.B.434/10.473;5avi.A.434/10.584;5avi.C.434/10.617;5avl.A.434/10.67;1uhl.B.434/10.394	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
428	L	none	none	none	none	-	12	0.06	alpha-helix	Helices	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/22.854;3ips.A.246/18.881;3ips.B.246/18.522;3ipu.A.246/18.468;3ipu.B.246/18.926;5avi.A.246/18.893;5avi.C.246/18.895;5avl.A.413/22.959;1uhl.B.413/23.404	3ipq.A.434/7.227;3ips.A.434/7.207;3ips.B.434/7.396;3ipu.A.434/6.756;3ipu.B.434/6.72;5avi.A.434/6.854;5avi.C.434/6.885;5avl.A.434/6.999;1uhl.B.434/7.646	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
429	R	none	none	none	none	-	124	0.45299999999999996	alpha-helix	Helices	Medium-buried	Positively Charged & Polar	-	-	-	-	3ipq.A.413/25.081;3ips.A.246/21.335;3ips.B.246/20.909;3ipu.A.246/20.608;3ipu.B.246/21.223;5avi.A.246/20.998;5avi.C.246/21.039;5avl.A.413/25.045;1uhl.B.413/24.581	3ipq.A.434/7.03;3ips.A.434/7.326;3ips.B.434/7.74;3ipu.A.434/6.789;3ipu.B.434/7.015;5avi.A.434/6.927;5avi.C.434/7.114;5avl.A.434/7.006;1uhl.B.434/5.754	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
430	L	none	none	none	none	-	127	0.632	alpha-helix	Helices	Medium-exposed	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/26.251;3ips.A.246/20.984;3ips.B.246/20.421;3ipu.A.246/19.863;3ipu.B.246/20.534;5avi.A.246/20.562;5avi.C.246/20.343;5avl.A.413/26.295;1uhl.B.413/26.568	3ipq.A.434/10.159;3ips.A.434/10.276;3ips.B.434/10.487;3ipu.A.434/9.714;3ipu.B.434/9.843;5avi.A.434/9.884;5avi.C.434/10.104;5avl.A.434/9.902;1uhl.B.434/9.114	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
431	Q	Q>E; Q>R	Q>E (exome, AC = 1, AN = 251452, AF = 3.9769e-06); Q>R (exome, AC = 1, AN = 251454, AF = 3.97687e-06)	none	none	-	96	0.42700000000000005	turn	coils	Medium-buried	Neutral & Polar	-	-	-	-	3ipq.A.312/26.712;3ips.A.246/17.161;3ips.B.246/16.571;3ipu.A.246/16.057;3ipu.B.246/16.713;5avi.A.246/16.741;5avi.C.246/16.524;5avl.A.312/26.227;1uhl.B.312/26.913	3ipq.A.434/8.74;3ips.A.434/9.227;3ips.B.434/9.135;3ipu.A.434/8.46;3ipu.B.434/8.504;5avi.A.434/8.788;5avi.C.434/8.936;5avl.A.434/8.75;1uhl.B.434/8.548	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
432	D	none	none	none	none	-	121	0.627	turn	coils	Medium-exposed	Negatively Charged & Polar	-	-	-	-	3ipq.A.314/27.988;3ips.A.246/18.127;3ips.B.246/17.2;3ipu.A.246/16.967;3ipu.B.246/17.411;5avi.A.246/17.1;5avi.C.246/17.217;5avl.A.312/27.106;1uhl.B.312/28.172	3ipq.A.434/6.183;3ips.A.434/6.388;3ips.B.434/6.242;3ipu.A.434/6.027;3ipu.B.434/5.817;5avi.A.434/5.772;5avi.C.434/6.027;5avl.A.434/6.755;1uhl.B.434/6.482	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
433	K	K>R	K>R (exome, AC = 2, AN = 251430, AF = 7.9545e-06)	none	none	-	55	0.233	loop	coils	buried	Positively Charged & Polar	-	-	-	-	3ipq.A.314/24.312;3ips.A.246/16.315;3ips.B.246/15.404;3ipu.A.246/15.436;3ipu.B.246/15.572;5avi.A.246/15.27;5avi.C.246/15.729;5avl.A.312/24.454;1uhl.B.314/25.038	3ipq.A.434/3.825;3ips.A.434/3.808;3ips.B.434/3.826;3ipu.A.434/3.787;3ipu.B.434/3.798;5avi.A.434/3.808;5avi.C.434/3.792;5avl.A.434/3.807;1uhl.B.434/3.902	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
434	K	K>N	K>N (exome, AC = 5, AN = 251438, AF = 1.98856e-05)	none	none	-	155	0.657	loop	coils	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ipq.A.314/24.109;3ips.A.246/18.389;3ips.B.246/17.703;3ipu.A.246/18.057;3ipu.B.246/18.269;5avi.A.246/17.99;5avi.C.246/18.458;5avl.A.314/25.093;1uhl.B.314/24.473	3ipq.A.434/0.0;3ips.A.434/0.0;3ips.B.434/0.0;3ipu.A.434/0.0;3ipu.B.434/0.0;5avi.A.434/0.0;5avi.C.434/0.0;5avl.A.434/0.0;1uhl.B.434/0.0	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2;E215-K434: Ligand-binding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
435	L	none	none	none	none	-	21	0.10400000000000001	loop	coils	buried	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/21.753;3ips.A.246/20.131;3ips.B.246/19.567;3ipu.A.246/19.759;3ipu.B.246/19.754;5avi.A.246/19.73;5avi.C.246/20.319;5avl.A.314/22.635;1uhl.B.314/23.271	3ipq.A.434/3.808;3ips.A.434/3.802;3ips.B.434/3.825;3ipu.A.434/3.781;3ipu.B.434/3.764;5avi.A.434/3.805;5avi.C.434/3.787;5avl.A.434/3.791;1uhl.B.434/3.636	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
436	P	none	none	none	none	-	28	0.17600000000000002	loop	coils	buried	Special	-	-	-	-	3ipq.A.314/21.657;3ips.A.246/21.511;3ips.B.246/20.949;3ipu.A.246/20.881;3ipu.B.246/20.731;5avi.A.246/20.876;5avi.C.246/21.53;5avl.A.314/22.73;1uhl.B.314/22.161	3ipq.A.434/6.343;3ips.A.434/6.514;3ips.B.434/6.386;3ipu.A.434/6.499;3ipu.B.434/6.448;5avi.A.434/6.723;5avi.C.434/6.64;5avl.A.434/6.404;1uhl.B.434/6.43	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
437	P	none	none	none	none	-	95	0.597	alpha-helix	Helices	Medium-exposed	Special	-	-	-	-	3ipq.A.314/24.231;3ips.A.314/25.013;3ips.B.246/24.611;3ipu.A.246/24.607;3ipu.B.246/24.427;5avi.A.246/24.665;5avi.C.314/25.063;5avl.A.314/25.182;1uhl.B.314/25.081	3ipq.A.434/8.833;3ips.A.434/9.178;3ips.B.434/8.807;3ipu.A.434/8.884;3ipu.B.434/8.774;5avi.A.434/9.234;5avi.C.434/9.072;5avl.A.434/9.013;1uhl.B.434/8.225	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
438	L	none	none	none	none	-	9	0.045	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/22.272;3ips.A.314/23.025;3ips.B.314/23.378;3ipu.A.314/23.188;3ipu.B.314/23.257;5avi.A.314/23.095;5avi.C.314/22.907;5avl.A.314/23.288;1uhl.B.314/22.797	3ipq.A.434/11.387;3ips.A.434/11.552;3ips.B.434/11.438;3ipu.A.434/11.369;3ipu.B.434/11.282;5avi.A.434/11.66;5avi.C.434/11.606;5avl.A.434/11.441;1uhl.B.434/10.145	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
439	L	none	none	none	none	-	1	0.005	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.314/20.552;3ips.A.314/21.283;3ips.B.314/21.669;3ipu.A.314/21.326;3ipu.B.314/21.396;5avi.A.314/21.293;5avi.C.314/21.089;5avl.A.314/21.405;1uhl.B.314/21.181	3ipq.A.434/9.568;3ips.A.434/9.595;3ips.B.434/9.809;3ipu.A.434/9.537;3ipu.B.434/9.489;5avi.A.434/9.756;5avi.C.434/9.712;5avl.A.434/9.629;1uhl.B.434/7.981	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
440	S	S>C	S>C (exome, AC = 64, AN = 251374, AF = 0.000254601); S>C (genome, AC = 6, AN = 31398, AF = 0.000191095)	none	none	-	28	0.18100000000000002	alpha-helix	Helices	buried	Neutral & Polar	-	-	-	-	3ipq.A.413/23.809;3ips.A.413/23.97;3ips.B.413/23.916;3ipu.A.413/23.992;3ipu.B.413/23.733;5avi.A.413/24.134;5avi.C.413/23.998;5avl.A.413/23.879;1uhl.B.413/23.59	3ipq.A.434/8.009;3ips.A.434/7.913;3ips.B.434/8.021;3ipu.A.434/7.79;3ipu.B.434/7.657;5avi.A.434/8.12;5avi.C.434/8.094;5avl.A.434/7.943;1uhl.B.434/6.64	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
441	E	none	none	none	none	-	21	0.094	alpha-helix	Helices	buried	NegativelyCharged & Polar	-	-	-	-	3ipq.A.413/24.309;3ips.A.413/24.425;3ips.B.413/24.413;3ipu.A.413/24.58;3ipu.B.413/24.363;5avi.A.413/24.468;5avi.C.413/24.398;5avl.A.413/24.418;1uhl.B.413/24.005	3ipq.A.434/11.642;3ips.A.434/11.543;3ips.B.434/11.64;3ipu.A.434/11.399;3ipu.B.434/11.223;5avi.A.434/11.785;5avi.C.434/11.735;5avl.A.434/11.534;1uhl.B.434/10.268	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
442	I	none	none	none	none	-	6	0.03	alpha-helix	Helices	core	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/20.677;3ips.A.413/20.841;3ips.B.413/20.792;3ipu.A.413/20.984;3ipu.B.413/20.759;5avi.A.413/20.829;5avi.C.413/20.764;5avl.A.413/20.784;1uhl.B.413/20.393	3ipq.A.434/13.454;3ips.A.434/13.4;3ips.B.434/13.397;3ipu.A.434/13.11;3ipu.B.434/12.98;5avi.A.434/13.322;5avi.C.434/13.32;5avl.A.434/13.208;1uhl.B.434/11.802	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
443	W	none	none	none	none	-	42	0.147	alpha-helix	Helices	buried	Aromatic & Hydrophobic	-	-	-	-	3ipq.A.413/19.177;3ips.A.413/19.288;3ips.B.413/19.107;3ipu.A.413/19.349;3ipu.B.413/19.086;5avi.A.413/19.224;5avi.C.413/19.219;5avl.A.413/19.229;1uhl.B.413/18.989	3ipq.A.434/11.634;3ips.A.434/11.449;3ips.B.434/11.603;3ipu.A.434/11.205;3ipu.B.434/11.135;5avi.A.434/11.444;5avi.C.434/11.394;5avl.A.434/11.289;1uhl.B.434/9.795	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
444	D	none	none	none	none	-	22	0.114	loop	coils	buried	Negatively Charged & Polar	-	-	-	-	3ipq.A.413/22.045;3ips.A.413/22.04;3ips.B.413/21.933;3ipu.A.413/22.124;3ipu.B.413/21.912;5avi.A.413/21.965;5avi.C.413/21.961;5avl.A.413/22.007;1uhl.B.413/21.782	3ipq.A.434/9.866;3ips.A.434/9.826;3ips.B.434/10.007;3ipu.A.434/9.552;3ipu.B.434/9.45;5avi.A.434/9.863;5avi.C.434/9.878;5avl.A.434/9.687;1uhl.B.434/10.489	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
445	V	V>M	V>M (exome, AC = 5, AN = 251180, AF = 1.9906e-05); V>M (genome, AC = 1, AN = 31412, AF = 3.1835e-05)	none	none	-	119	0.684	loop	coils	Medium-exposed	Aliphatic & Hydrophobic	-	-	-	-	3ipq.A.413/22.926;3ips.A.413/22.666;3ips.B.413/22.887;3ipu.A.413/22.914;3ipu.B.413/22.733;5avi.A.413/22.85;5avi.C.413/22.805;5avl.A.413/22.579;1uhl.B.413/23.914	3ipq.A.434/12.76;3ips.A.434/12.732;3ips.B.434/13.001;3ipu.A.434/12.515;3ipu.B.434/12.371;5avi.A.434/12.775;5avi.C.434/12.764;5avl.A.434/12.804;1uhl.B.434/7.647	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
446	H	H>D	H>D (exome, AC = 1, AN = 251088, AF = 3.98267e-06)	none	none	-	157	0.701	loop	coils	Medium-exposed	Positively Charged & Polar	-	-	-	-	3ips.A.413/26.269;3ips.B.413/26.561;5avi.A.413/26.522;5avi.C.413/26.554;5avl.A.413/26.361	3ips.A.434/13.234;3ips.B.434/13.462;5avi.A.434/13.455;5avi.C.434/12.723;5avl.A.434/13.249	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
447	E	none	none	none	none	-	220	0.987	loop	coils	exposed	NegativelyCharged & Polar	-	-	-	-	5avl.A.413/27.792	5avl.A.434/16.765	-	-	-	-	-	-	-	-	-	Q205-E447: Transactivation AF-2 required for ligand-dependent transactivation function mediates interaction with CCAR2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	region	-	-	-
